Archived Publications

2023

RII authors are marked with an asterisk(*); — indexed by Scopus; — indexed by Web of Science.

1. 5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro
   Chistov A.A., Chumakov S.P., Mikhnovets I.E., Nikitin T.D., Slesarchuk N.A., Uvarova V.I., Rubekina A.A., Nikolaeva* Yu.V., Radchenko E.V., Khvatov E.V., Orlov A.A., Frolenko V.S., Sukhorukov M.V., Kolpakova E.S., Shustova E.Y., Galochkina* A.V., Streshnev Ph.P., Osipov E.M., Sapozhnikova K.A., Moiseenko A.V., Brylev V.A., Proskurin G.V., Dokukin Yu.S., Kutyakov S.V., Aralov A.V., Korshun V.A., Strelkov S.V., Palyulin V.A., Ishmukhametov A.A., Shirshin E.A., Osolodkin D.I., Shtro* A.A., Kozlovskaya L.I., Alferova V.A., Ustinov A.V.
   Antiviral Research — 2023. — Vol. 209. — Issue. . — pp. 105508-
   DOI: 10.1016/j.antiviral.2022.105508
2. A Genome of Temperate Enterococcus Bacteriophage Placed in a Space of Pooled Viral Dark Matter Sequences
   Pchelin I.M., Tkachev P.V., Azarov D.V., Gorshkov* A.N., Drachko D.O., Zlatogursky V.V., Dmitriev A.V., Goncharo A.E.
   Viruses — 2023. — Vol. 15. — Issue. 1. — pp. 216-
   DOI: 10.3390/v15010216
3. Abietic, maleopimaric and quinopimaric dipeptide Ugi-4CR derivatives and their potency against influenza A and SARS-CoV-2
   Tretyakova E.V., Ma X., Kazakova O.B., Shtro* A.A., Petukhova G. D., Smirnova A.A., Xu H., Xiao S.
   Natural Product Research — 2023. — Vol. 37. — Issue. 12. — pp. 1954-1960
   DOI: 10.1080/14786419.2022.2112040
4. Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent
   Chilingaryan G., Izmailyan R., Grigoryan R., Shavina A., Arabyan E., Khachatryan H., Abelyan N., Matevosyan Mh., Harutyunyan V., Manukyan G., Hietel B., Shtro* A., Danilenko* D., Zakaryan H.
   Antiviral Research — 2023. — Vol. 217. — Issue. . — pp. 105681-
   DOI: 10.1016/j.antiviral.2023.105681
5. Age differences in comorbidities, presenting symptoms and outcomes of influenza illness requiring hospitalization: a worldwide perspective from the Global Influenza Hospital Surveillance Network
   Andrew, M.K., Pott, H., Staadegaard, L., Paget, J., Chaves, S.S., Ortiz, J.R., McCauley, J., Bresee, J., Nunes, M.C., Baumeister, E. and Raboni, S.M., Giamberardino H.I.G., McNeil S.A, Gomez D., Zhang T., Vanhems P., Koul P.A., Coulibaly D., Otieno N.A., Dbaibo G., Almeida M.L.G., Laguna-Torres V.A., Drăgănescu A.C., Burtseva E., Sominina* A., Danilenko* D., Medić S., Diez-Domingo J., Lina B. on behalf of GIHSN investigators
   Open Forum Infectious Diseases — 2023. — Vol. . — Issue. . — pp. -
   DOI: 10.1093/ofid/ofad244
6. An acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs—a randomized clinical trial
   Luoma J.B., Rossi S.L., Sereda Y., Pavlov N., Toussova O., Vetrova M., Bendiks S., Kiriazova T., Krupitsky E., Lioznov* D., Blokhina E., Ludi S., Luzne K.
   TheLancetRegional Health-Europe — 2023. — Vol. 28. — Issue. . — pp. 100611-
   DOI: 10.1016/j.lanepe.2023.100611
7. An Early SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint Petersburg, Russia
   Klink G.V., Danilenko* D.M., Komissarov* A.B., Yolshin* N., Shneider* O.V., Shcherbak S., Nabieva E., Shvyrev N., Konovalova* N., Zheltukhina* A., Fadeev* A., Komissarova* K., Ksenafontov* A., Musaeva* T., Eder* V., Pisareva* M., Nekrasov* P.A., Shchur V., Bazykin* G.A., Lioznov* D.
   Viruses — 2023. — Vol. 15. — Issue. 7. — pp. 1415-
   DOI: 10.3390/v15071415
8. An Ultrastructural and Immunohistochemical Assessment of Polyposis Tissue in Chronic Polyposis Rhinosinusitis
   Gorshkov* A.N., Varyushina* E.A., Bezrukova E.V., Aflitonov M.A., Simbirtsev A.S.
   Cell and Tissue Biology — 2023. — Vol. 17. — Issue. 1. — pp. 83-95
   DOI: 10.1134/S1990519X23010042
9. Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation
   Sominina* A.A., Danilenko* D.M., Komissarov* A.B., Pisareva* M.M., Fadeev* A.V., Konovalova* N.I., Eropkin* M. Yu., Petrova* P.A., Zheltukhina* A.S., Musaeva* T.D., Eder* V., Ivanova* A.A., Komissarova* K.S., Stolyarov* K.A., Karpova* L.S., Smorodintseva* E.A., Dorosh* A.V., Krivitskaya* V.Z., Kuznetzova* E.V., Majorova* V.G., Petrova* E.R., Boyarintseva* A.Yu., Ksenafontov* A., Shtro* A.A., Nikolaeva* J.V., Bakaev* M., Burtseva E., Lioznov* D.A.
   Viruses — 2023. — Vol. 15. — Issue. 8. — pp. 1780-
   DOI: 10.3390/v15081780
10. Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
    Vasin* A.V., Stukova* M.A.
    The Lancet Infectious Diseases — 2023. — Vol. . — Issue. . — pp. -
    DOI: 10.1016/S1473-3099(23)00189-5
11. Comparative Study of the Myocardium of Patients from Four COVID-19 Waves
    Mitrofanova L.B., Makarov I.A., Gorshkov* A.N., Runov A.L., Vonsky M.S., Pisareva* M.M., Komissarov* A.B., Makarova T.A., Li Q., Karonova T.L., Konradi A.O., Shlaykhto E.V.
    Diagnostics — 2023. — Vol. 13. — Issue. 9. — pp. 1645-
    DOI: 10.3390/diagnostics13091645
12. Copolymers of Sodium Styrene Sulfonate and 2-Deoxy-2-methacrylamido-D-glucose with Antiviral Activity
    Panarin E.F., Zhuravskaya O.N., Shtro* A.A.
    Polymer Science, Series B — 2023. — Vol. . — Issue. . — pp. 1-4
    DOI: 10.1134/S1560090423700793
13. Correlates of Intersectional HIV and Substance Use Stigma Affecting People with HIV and Substance Use in St. Petersburg, Russia
    Lodi S., Rossi S.L., Bendiks S., Gnatienko N., Lloyd-Travaglini C., Vetrova M., Toussova O., Bushara N., Blokhina E., Krupitsky E., Ekstrand M.L., Lioznov* D., Samet J.H., Lunze K.
    AIDS and Behavior — 2023. — Vol. 27. — Issue. 2. — pp. 462-472
    DOI: 10.1007/s10461-022-03781-8
14. COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
    Belozerov K.E., Avrusin I.S., Andaryanova L.I., Guseva A.M., Shogenova Z.S., Belanovich I.N., Lobacheva A.V., Kornishina T.L., Isupova E.A., Masalova V.V., Kalashnikova O.V., Nokhrin A.V., Panova T.F., Dutova Yu.P., Myshkovskaya S.L., Kostyunin K.Y., Komissarov* A.B., Chasnyk V.G., Bregel L.V., Kostik M.M.
    Biomedicines — 2023. — Vol. 11. — Issue. 3. — pp. 870-
    DOI: 10.3390/biomedicines11030870
15. Detection and Differentiation of Current Influenza B Viruses by the Microculture Enzyme-Linked Immunosorbent Assay Using Monoclonal Antibodies
    Krivitskaya* V.Z., Majorova* V.G., Sorokin* E.V., Tsareva* T.R., Pisareva* M.M., Zheltukhina* A.I., Petrova* E.R., Kuznetzova* E.V., Kadyrova* R.A., Danilenko* D.M., Sominina* A.A.
    Applied Biochemistry and Microbiology — 2023. — Vol. 59. — Issue. . — pp. 1039-1046
    DOI: 10.1134/S0003683823070037
16. Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens
    Stosman* K.I., Aleksandrov* A.G., Sivak* K.V., Buzitskaya* Z.V., Stukova* M.A.
    Iranian Journal of Basic Medical Sciences — 2023. — Vol. 26. — Issue. 5. — pp. 558-563
    DOI: 10.22038/IJBMS.2023.68440.14936
17. Highly Pathogenic Avian Influenza A(H5N1) Virus–Induced Mass Death of Wild Birds, Caspian Sea, Russia, 2022.
    Sobolev I., Gadzhiev A., Sharshov K., Ohlopkova O., Stolbunova K., Fadeev* A.V., Dubovitskiy N., Glushchenko A., Irza V., Perkovsky M., Litvinov K., Meshcheriakova N., Petherbridge G., Shestopalov A.
    Emerging Infectious Diseases — 2023. — Vol. 29. — Issue. 12. — pp. 2528-2532
    DOI: 10.3201/eid2912.230330
18. Identification and Study of the Action Mechanism of Small Compound That Inhibits Replication of Respiratory Syncytial Virus
    Shtro* A.A, Klabukov* A.M., Garshinina* A.V., Galochkina* A.V., Nikolaeva* Yu.V., Khomenko T.M., Bobkov* D.E., Lozhkov* A.A., Sivak* K.V., Yakovlev* K.S., Komissarov* A.B., Borisevich S.S., Volcho K.P., Salakhutdinov N.F.
    International Journal of Molecular Sciences — 2023. — Vol. 24. — Issue. 16. — pp. 12933-
    DOI: 10.3390/ijms241612933
19. IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice
    òulkina* A.A., Vasilyev* K.A., Muzhikyan* A.A., Sergeeva* M.V., Romanovskaya-Romanko* E.A., Shurygina* A.-P.S., Shuklina* M.A., Vasin* A.V., Stukova* M.A. and Egorov* A.Yu.
    International Journal of Molecular Sciences — 2023. — Vol. 24. — Issue. 14. — pp. 11445-
    DOI: 10.3390/ijms241411445
20. Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
    Lioznov* D.A., Amosova* I.V., Sheetikov S.A., Zornikova K.V., Serdyuk Y., Efimov G.A., Tsyferov M., Khmelevskii M., Afanasiev A., Khomyakova N., Zubkov D. Tikhonov A., Zhu T., Barreto L., Dzutseva V.
    PLoS ONE — 2023. — Vol. 18. — Issue. 3. — pp. e0278878-
    DOI: 10.1371/journal.pone.0278878
21. Influenza A(H1N1)pdm09 Virus Aggravates Pathology of Blood Vessels in Wistar Rats with Premorbid Acute Cardiomyopathy
    Marchenko* V., Zelinskaya I., Toropova Y., Podyacheva E., Martynov M., Mukhametdinova D., Lioznov* D., Zhilinskaya* I.N.
    Viruses — 2023. — Vol. 15. — Issue. 5. — pp. 1114-
    DOI: 10.3390/v15051114
22. Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes
    Kokinos E.K., Tsymbal S.A., Galochkina* A.V., Bezlepkina S.A., Nikolaeva* J.V., Vershinina S.O., Shtro* A.A., Tatarskiy V.V., Shtil A.A., Broude E.V., Roninson I.B., Dukhinova M.
    Viruses — 2023. — Vol. 15. — Issue. 6. — pp. 1292-
    DOI: 10.3390/v15061292
23. Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure
    Egorov* V.V., Shvetsov A.V., Pichkur E.B., Shaldzhyan* A.A., Zabrodskaya* Ya.A., Vinogradova D.S., Nekrasov* P.A., Gorshkov* A.N., Garmay Yu.P., Kovaleva* A.A., Stepanova* L.A., Tsybalova* L.M., Shtam T.A., Myasnikov A.G., Konevega A.L.
    Biophysical Chemistry — 2023. — Vol. 293. — Issue. . — pp. 106943-
    DOI: 10.1016/j.bpc.2022.106943
24. Kinetics of interferon-λ and receptor expression in response to in vitro respiratory viral infection
    Lozhkov* A.A., Yolshin* N.D., Baranovskaya* I.L., Plotnikova* M.A., Sergeeva* M.V., Gyulikhandanova* N.E., Klotchenko* S.A., Vasin* A.V.
    Acta Virologica — 2023. — Vol. 67. — Issue. 1. — pp. 99-108
    DOI: 10.4149/av_2023_110
25. Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
    Sergeeva* M.V., Romanovskaya-Romanko* E.A., Krivitskaya* V.Z., Kudar P.A., Petkova N.N., Kudria* K.S., Lioznov* D.A., Stukova* M.A., Desheva J.A.
    Vaccines — 2023. — Vol. 11. — Issue. 11. — pp. 1731-
    DOI: 10.3390/vaccines11111731
26. Matrix is everywhere: extracellular DNA is a link between biofilm and mineralization in Bacillus cereus planktonic lifestyle
    Ivanova L., Egorov* V.V., Zabrodskaya* Ya.A., Shaldzhyan* A.A., Baranchikov A., Tsvigun N., Lykholay A. Yapryntsev A., Lebedev D., Kulminskaya,A.
    npj Biofilms and Microbiomes — 2023. — Vol. 9. — Issue. 1. — pp. 9-
    DOI: 10.1038/s41522-023-00377-5
27. New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
    Khomenko, T.M., Shtro*, A.A., Galochkina*, A.V., Nikolaeva*, Y.V., Garshinina*, A.V., Borisevich, S.S., Korchagina, D.V., Volcho, K.P. and Salakhutdinov, N.F.
    Molecules — 2023. — Vol. 28. — Issue. 6. — pp. 2673-
    DOI: 10.3390/molecules28062673
28. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
    Wilkins D., Langedijk A.C., Lebbink R.J., Morehouse C., Abram M.E., Ahani B., Aksyuk A.A., Baraldi E., Brady T., Chen A.T., Chi H., Cohen R., Danilenko* D.M., Gopalakrishnan G., Greenough A., Heikkinen T., Hosoya M., Keller C., Kelly E.J., Kragten-Tabatabaie L., Martinón-Torres F., Mascareñas de Los Santos A.H., Nunes M.C., Palomino M.A., Papenburg J., Pernica J.M., Richmond P., Stein R.T., Tuffy K.M., Verwey C., Esser M.T, Tabor D.E., Bont L.J.
    The Lancet Infectious Diseases — 2023. — Vol. . — Issue. . — pp. -
    DOI: 10.1016/S1473-3099(23)00062-2
29. Non-invasive transcutaneous influenza immunization using vaccine-loaded vaterite particles
    Svenskaya Y.I., Lengert E.V., Tarakanchikova Y.V., Muslimov A.R., Saveleva M.S., Genina E.A., Radchenko I.L., Stepanova L.A., Vasin* A.V., Sukhorukov G.B. and Tsybalova* L.M.
    Journal of Materials Chemistry B — 2023. — Vol. 11. — Issue. 17. — pp. 3860-3870
    DOI: 10.1039/D2TB02779H
30. Nosocomial RSV-related In-hospital Mortality in Children <5 years:="" a="" global="" case="" series="" b="">
    Löwensteyn YN, Willemsen JE, Mazur NI, Scheltema NM, van Haastregt NCJ, Buuren AAAT, van Roessel I, Scheepmaker D, Nair H, van de Ven PM, Bont LJ; on behalf of the RSV GOLD Study Group (…, Stolyarov* K.A., ...)
    The Pediatric Infectious Disease Journal — 2023. — Vol. 42. — Issue. 1. — pp. 1-7
    DOI: 10.1097/INF.0000000000003747
31. Peptide from NSP7 is able to form amyloid-like fibrils: Artifact or challenge to drug design?
    Garmay Y., Rubel A., Egorov* V.
    Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics — 2023. — Vol. 1871. — Issue. 2. — pp. 140884-
    DOI: 10.1016/j.bbapap.2022.140884
32. Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope
    Blokhina E.A., Mardanova E.S., Zykova A.A., Stepanova* L.A., Shuklina* M.A., Tsybalova* L.M., Ravin N.V
    Plants — 2023. — Vol. 12. — Issue. 11. — pp. 2228-
    DOI: 10.3390/plants12112228
33. Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
    Shurygina* A.-P., Zabolotnykh N., Vinogradova T., Khairullin B., Kassenov M., Nurpeisova A., Sarsenbayeva G., Sansyzbay A., Vasilyev* K., Buzitskaya* J., Egorov* A., Stukova* M.
    International Journal of Molecular Sciences — 2023. — Vol. 24. — Issue. 8. — pp. 7439-
    DOI: 10.3390/ijms24087439
34. Properties of recombinant extracellular N-terminal domain of human high-affinity copper transporter 1 (hNdCTR1) and its interactions with Cu(ii) and Ag(i) ions
    Orlov I.A., Sankova T.P., Skvortsov A.N., Klotchenko* S.A., Sakhenberg E.I., Mekhova A.A., Kiseleva I.V., Ilyechova E.Y., Puchkova L.V.
    Dalton Transactions — 2023. — Vol. 52. — Issue. 11. — pp. 3403-3419
    DOI: 10.1039/D2DT04060C
35. Reorganization and Suppression of Store-Operated Calcium Entry in Podocytes of Type 2 Diabetic Rats
    Gusev K., Shalygin A., Kolesnikov D., Shuyskiy L., Makeenok S., Glushankova L., Sivak* K., Yakovlev* K., Orshanskaya* Y., Wang G., Bakhtyukov A., Derkach K., Shpakov A., Kaznacheyeva E.
    International Journal of Molecular Sciences — 2023. — Vol. 24. — Issue. 8. — pp. 7259-
    DOI: 10.3390/ijms24087259
36. Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020
    Williams T., Jackson S., Barr I., Bi S., Bhiman J., Ellis J., von Gottberg A., Lindstrom S., Peret T., Rughooputh S., Viegas V., Hirve S., Zambon V., Zhang W., WHO RSV Surveillance Group (Dakhilalla A., …, Pisareva* M., …, Deng Y. M.)
    Influenza and Other Respiratory Viruses — 2023. — Vol. 17. — Issue. 1. — pp. e13073-
    DOI: 10.1111/irv.13073
37. Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
    Kudriavtsev A.V., Vakhrusheva A. V., Kryuchkov N.A., Frolova M. E., Blagodatskikh K.A., Ivanishin T. V., Djonovic M., Romanovskaya-Romanko* E.A., Kovalenko A.N., Lioznov* D.A., Zubkova* T.G., Teplykh S.V., Oseshnyuk R.A., Stukova* M.A., Krasilnikov* I.V.
    Vaccines — 2023. — Vol. 11. — Issue. 2. — pp. 326-
    DOI: 10.3390/vaccines11020326
38. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
    Stanevich* O.V., Alekseeva E.I., Sergeeva* M.V., Fadeev* A.V., Komissarova* K.S., Ivanova* A.A., Simakova T.S., Vasilyev* K.A., Shurygina* A.P., Stukova* M.A., Safina K.R., Nabieva E.R., Garushyants S.K., Klink G.V., Bakin E.A., Zabutova J.V., Kholodnaia A.N., Lukina O.V., Skorokhod I.A., Ryabchikova V.V., Medvedeva N.V., Lioznov* D.A., Danilenko* D.M., Chudakov D.M., Komissarov* A.B., Bazykin G.A.
    Nature Communications — 2023. — Vol. 14. — Issue. . — pp. 149-
    DOI: 10.1038/s41467-022-34033-x
39. Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022
    Meslé M.M.I., Sinnathamby M., Mook P., WHO European Region Respiratory Network Group (Pebody R., …, Komissarova* K.S., Stolyarov* K.A., …, Vladimirova N.)
    Influenza and other respiratory viruses — 2023. — Vol. 17. — Issue. 11. — pp. e13219-
    DOI: 10.1111/irv.13219
40. Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine
    Kordyukova L.V. , Moiseenko A.V., Serebryakova M.V., Shuklina* M.A., Sergeeva* M.V., Lioznov* D.A., Shanko A.V.
    Viruses — 2023. — Vol. 15. — Issue. 2. — pp. 480-
    DOI: 10.3390/v15020480
41. Synthesis of berberine derivatives and their antiviral activity toward respiratory syncytial virus
    Shtro* A.A., Gladkova, E.D., Galochkina* A.V., ...Luzina, O.A., Salakhutdinov, N.F.
    Medicinal Chemistry Research — 2023. — Vol. 32. — Issue. . — pp. 2325-2333
    DOI: 10.1007/s00044-023-03138-3
42. The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020–2022 Period
    Palyanova N.V., Sobolev I.A., Palyanov A.Y., Kurskaya O.G., Komissarov* A.B., Danilenko* D.M., Fadeev* A.V., Shestopalov A.M.
    Viruses — 2023. — Vol. 15. — Issue. 10. — pp. 2014-
    DOI: 10.3390/v15102014
43. The impacts of COVID-19 on structural inequities faced by people living with HIV who inject drugs: A qualitative study in St. Petersburg, Russia
    Carroll J.J., Rossi S.L., Vetrova M.V., Blokhina E., Sereda Y., Lioznov* D., Luoma J., Kiriazova T., Lunze K.
    International Journal of Drug Policy — 2023. — Vol. 117. — Issue. . — pp. 104060-
    DOI: 10.1016/j.drugpo.2023.104060
44. Uncertainty Estimation for Quantitative Agarose Gel Electrophoresis of Nucleic Acids
    Semenov K., Taraskin* A., Yurchenko A., Baranovskaya I., Purvinsh L., Gyulikhandanova* N., Vasin* A.
    Sensors — 2023. — Vol. 23. — Issue. 4. — pp. 1999-
    DOI: 10.3390/s23041999
45. Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
    Basukala B., Rossi S., Bendiks S., Gnatienko N., Patts G., Krupitsky E., Lioznov* D., So-Armah K., Sagar M., Cheng C., Henderson A.J.
    Viruses — 2023. — Vol. 15. — Issue. 2. — pp. 415-
    DOI: 10.3390/v15020415
46. Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia
    Dubovitskiy N., Derko A., Sobolev I., Prokopyeva E., Murashkina T., Solomatina M., Kurskaya O., Komissarov* A., Fadeev* A., Danilenko* D., Petrova* P., Mine J., Tsunekuni R., Uchida Y., Saito T., Shestopalov A., Sharshov K.
    Viruses — 2023. — Vol. 15. — Issue. 3. — pp. 734-
    DOI: 10.3390/v15030734

2022

RII authors are marked with an asterisk(*); — indexed by Scopus; — indexed by Web of Science.

1. A comparative analysis of the epidemiology of influenza and respiratory syncytial virus in Russia, 2013/14 to 2018/19
   Caini S., Stolyarov* K., Sominina* A., Smorodintseva* E., Staadegaard L., Paget J., Danilenko* D.
   Journal of Global Health — 2022. — Vol. 12. — Issue. . — pp. 4009-
   DOI: 10.7189/jogh.12.04009
2. A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
   Buzitskaya* Z., Stosman* K., Khairullin B., Kassenov M., Nurpeisova A., Sansyzbay A.A., Shurygina* A.P., Aleksandrov* A., Sivak* K., Stukova* M.
   Drug Research — 2022. — Vol. . — Issue. . — pp. -
   DOI: 10.1055/a-1785-3936
3. A novel method for multiplex protein biomarker analysis of human serum using quantitative MALDI mass spectrometry
   Taraskin* A.S., Semenov K.K., Lozhkov* A.A., Baranovskaya* I.L., Protasov* A.V., Ramsay* E.S., Tyulin A.A., Mirgorodskaya* O.A., Vasin* A.V., Klotchenko* S.A., Zabrodskaya* Y.A.
   Journal of Pharmaceutical and Biomedical Analysis — 2022. — Vol. 210. — Issue. . — pp. 114575-
   DOI: 10.1016/j.jpba.2021.114575
4. Abietic, maleopimaric and quinopimaric dipeptide Ugi-4CR derivatives and their potency against influenza A and SARS-CoV-2
   Tretyakova E.V., Ma X., Kazakova O.B., Shtro* A.A., Petukhova* G.D., Smirnova A.A., Xu H., Xiao S.
   Natural Product Research — 2022. — Vol. . — Issue. . — pp. 1-7
   DOI: 10.1080/14786419.2022.2112040
5. Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents
   Kudryavtsev I.V., Isakov D.V., Batsunov O.K., Kuznetsova R.N., Rubinstein A.A., Stanevich* O.V., Lebedeva A.A., Vorobyov E.A., Vorobyova S.V., Kulikov A.N., Sharapova M.A., Pevtcov D.E., Totolian A.A., Arsentieva N.A., Korobova Z.R., Khamitova I.V.
   Current Issues in Molecular Biology — 2022. — Vol. 44. — Issue. 1. — pp. 194-205
   DOI: 10.3390/cimb44010014
6. Analysis of the Safety and Immunogenicity Profile of an Azoximer Bromide Polymer-Adjuvanted Subunit Influenza Vaccine
   Kompier R., Neels P., Beyer W., Hardman T., Lioznov* D., Kharit S., Kostinov M.
   F1000Research — 2022. — Vol. 11. — Issue. . — pp. 259-
   DOI: 10.12688/f1000research.75869.1
7. Clinical and phylogenetic influenza dynamics for the 2019-20 season in the global influenza hospital surveillance network (GIHSN) – Pilot study
   Quéromès G., Frobert E., Burtseva E., Drăgănescu A., Koul P.A., Komissarov* A., Alberto Laguna-Torres V., Leblanc J., Lopez-Labrador F-X., Medić S., Mironenko A., Otieno N.A., Ruiz-Palacios G.M., Tanriover B., NGS team - Lyon, GIHSN collaborators(...Bakaev* M., Danilenko* D., Fadeev* A., Pisareva* M., Sominina* A., ...), Josset L., Lina B.
   Journal of Clinical Virology — 2022. — Vol. 152. — Issue. . — pp. 105184-
   DOI: 10.1016/j.jcv.2022.105184
8. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data
   Barchuk A., Skougarevskiy D., Kouprianov A., Shirokov D., Dudkina O., Tursun-Zade R., Sergeeva* M., Tychkova* V., Komissarov* A., Zheltukhina* A., Lioznov* D., Isaev A., Pomerantseva E., Zhikrivetskaya S., Sofronova Y., Blagodatskikh K., Titaev K., Barabanova L., Danilenko* D.
   PLoS ONE — 2022. — Vol. 17. — Issue. 6. — pp. e0266945-
   DOI: 10.1371/journal.pone.0266945
9. CRISPR-Cas9 mediated knockout of AnxA6 gene enhances influenza A virus replication in low-permissive HEK293FT cell line
   Komissarov* A., Sergeeva* M., Zhuravlev E., Medvedev S., Malakhova A., Andreeva E., Shurygina* A.P., Gorshkov* A., Timofeeva M., Balakhonova E., Grudinin* M., Zakian S., Richter V., Stepanov G.
   Gene — 2022. — Vol. 809. — Issue. . — pp. 146024-
   DOI: 10.1016/j.gene.2021.146024
10. Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2
    Krasilnikov* I.V., Kudriavtsev A.V., Vakhrusheva A.V., Frolova M.E., Ivanov A.V., Stukova* M.A., Romanovskaya-Romanko* E.A., Vasilyev* K.A., Mushenkova N.V., Isaev A.A.
    Vaccines — 2022. — Vol. 10. — Issue. 1. — pp. 69-
    DOI: 10.3390/vaccines10010069
11. Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR
    Yolshin* N.D., Komissarov* A.B., Varchenko* K.V., Musaeva* T.D., Fadeev* A.V., Lioznov* D.A.
    International Journal of Molecular Sciences — 2022. — Vol. 23. — Issue. 24. — pp. 16153-
    DOI: 10.3390/ijms232416153
12. Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
    Isakova-Sivak I., Stepanova E., Matyushenko V., Niskanen S., Mezhenskaya D., Bazhenova E., Krutikova E., Kotomina T., Prokopenko P., Neterebskii B., Doronin A., Vinogradova E., Yakovlev* K., Sivak* K., Rudenko L.
    Vaccines — 2022. — Vol. 10. — Issue. 7. — pp. 1142-
    DOI: 10.3390/vaccines10071142
13. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
    Sultankulova K., Chervyakova O., Myrzakhmetova B., Nakhanov A., Nurpeisova A., Zhugunissov K., Assanzhanova Nurikaa., Nurabayev S., Kerimbayev A. Yershebulov Z., Burashev Y., Kulmagambetov I., Davlyatshin T., Sergeeva* M., Buzitskaya* Z., Stukova* M., Kutumbetov L.
    EClinicalMedicine — 2022. — Vol. 50. — Issue. . — pp. 101526-
    DOI: 10.1016/j.eclinm.2022.101526
14. Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis
    Gorshkov* A., Purvinsh* L., Brodskaia* A., Vasin* A.
    Nanomaterials — 2022. — Vol. 12. — Issue. 3. — pp. 524-
    DOI: 10.3390/nano12030524
15. Fatty Acid Changes in Nearshore Phytoplankton under Anthropogenic Impact as a Biodiversity Risk Factor for the World’s Deepest Lake Baikal
    Nikonova A.A., Shishlyannikov* S.M., Volokitina N.A., Galachyants Y.P., Bukin Y.S., Blinov V.V., Gnatovsky R.Y., Vorobyeva S.S.
    Diversity — 2022. — Vol. 14. — Issue. 1. — pp. 55-
    DOI: 10.3390/d14010055
16. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
    Halperin S.A., Ye L., MacKinnon-Cameron D., Smith B., Cahn P.E., Ruiz-Palacios G.M., Ikram A., Lanas F., Guerrero M.L., Navarro S.R.M., Sued O., Lioznov* D.A., Dzutseva V., Parveen G., Zhu F., Leppan L., Langley J.M., Barreto L., Gou J., Zhu T., for the CanSino COVID-19 Global Efficacy Study Group (Mao H., ..., Rozhkova* E., Zubkova* T.)
    The Lancet — 2022. — Vol. 399. — Issue. 10321. — pp. 237-248
    DOI: 10.1016/S0140-6736(21)02753-7
17. Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
    Tsybalova* L.M., Stepanova* L.A., Shuklina* M.A., Vasiliev* K.A., Kovaleva* A.A., Vidyaeva* I.G., Zabrodskaya* Y.A., Korotkov* A.V.
    Vaccines — 2022. — Vol. 10. — Issue. 12. — pp. 2098-
    DOI: 10.3390/vaccines10122098
18. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
    Li Y., Wang X., Blau D.M., Caballero M.T., Feikin D.R., Gill C.J., Madhi S.A., Omer S.B., Simões E.A.F., Campbell H., Bermejo Pariente A., Bardach D., Bassat Q., Casalegno J.-S., Chakhunashvili G., Crawford N., Danilenko* D., Lien Anh Ha Do, Echavarria M., Gentile A., Gordon A., Heikkinen T., Q Sue Huang†, Jullien S., Krishnan A., Lopez E.L., Markić J., Mira-Iglesias A., Moore H.C., Moyes J., Mwananyanda L., Nokes D.J., Noordeen F., Obodai E., Palani N., Romero C., Salimi V., Satav A., Seo E., Shchomak Z., Singleton R., Stolyarov* K., Stoszek S.K., von Gottberg A., Wurzel D., Lay-Myint Yoshida, Chee Fu Yung, Zar H.J., Respiratory Virus Global Epidemiology Network, Nair H., for the RESCEU investigators
    The Lancet — 2022. — Vol. . — Issue. . — pp. -
    DOI: 10.1016/S0140-6736(22)00478-0
19. Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data
    Kostik M.M., Bregel L.V., Avrusin I.S., Efremova O.S., Belozerov K.E., Dondurei* E.A., Kornishina T.L., Isupova E.A., Abramova N.N., Felker E.Y., Masalova V.V., Santimov A.V., Kozlov Yu.A., Barakin A.O., Snegireva L.S., Konstantinova J., Vilnits A.A., Bekhtereva M.K., Argunova V.M., Matyunova A.E., Sleptsova P.A., Burtseva T.E., Shprakh V.V., Boyko T.V., Kalashnikova O.V., Chasnyk V.G.
    Frontiers in Pediatrics — 2022. — Vol. 10. — Issue. . — pp. 829420-
    DOI: 10.3389/fped.2022.829420
20. Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization
    Karyagina A.S., Gromov A.V., Grunina T.M., Lyaschuk A.M., Poponova M.S., Kleymenov D.A., Strukova N.V., Generalova M.S., Ryazanova A.V., Galushkina Z.M., Dobrynina O.Y., Bolshakova T.N., Sergeeva* M.V., Romanovskaya-Romanko* E.A., Krasilnikov I.V., Subbotina M.E., Lunin V.G.
    Biochemistry — 2022. — Vol. 87. — Issue. 4. — pp. 319-330
    DOI: 10.1134/S0006297922040022
21. Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice
    Schapovalova O., Gorlova A., de Munter J., Sheveleva E., Eropkin* M., Gorbunov N., Sicker M., Umriukhin A., Lyubchyk S., Lesch K-P., Strekalova T., Schroeter C.A.
    Frontiers in Medicine — 2022. — Vol. 9. — Issue. . — pp. 952977-
    DOI: 10.3389/fmed.2022.952977
22. Impact of illicit opioid use on markers of monocyte activation and systemic inflammation in people living with HIV
    Kholodnaia A., Lioznov* D., So-Armah K., Samet J.H., Cheng D., Gnatienko N., Patts G., Freiberg M.
    PLoS ONE — 2022. — Vol. 17. — Issue. 5. — pp. e0265504-
    DOI: 10.1371/journal.pone.0265504
23. Impact of TB Prevention Measures and Capacity of TB Facilities on HIV/TB Incidence in the Russian Arctic (÷ÌÉÑÎÉÅ ÍÅÒ ÐÏ ÐÒÏÆÉÌÁËÔÉËÅ ÔÕÂÅÒËÕÌÅÚÁ É ×ÏÚÍÏÖÎÏÓÔÅÊ ÐÒÏÔÉ×ÏÔÕÂÅÒËÕÌÅÚÎÙÈ ÕÞÒÅÖÄÅÎÉÊ ÎÁ ÚÁÂÏ- ÌÅ×ÁÅÍÏÓÔØ ÷éþ/ôâ × òÏÓÓÉÊÓËÏÊ áÒËÔÉËÅ)
    Zagdyn Z.M., Tsvetkov* V.V., Zhao Y.
    Russian Journal of Infection and Immunity — 2022. — Vol. 10. — Issue. 1. — pp. 34-43
    DOI: 10.37482/2687-1491-Z088
24. In vitro and in vivo pharmacodynamic activity of the new compound XC221GI in models of the viral inflammation of the respiratory tract
    Stukova* í.á., Rydlovskaya A.V., Proskurina O. V., Mochalov S.V., Shurygina * A.-P. S., Nebolsin V.E.
    Microbiology Independent Research Journal (MIR Journal) — 2022. — Vol. 9. — Issue. 1. — pp. 56-70
    DOI: 10.18527/2500-2236-2022-9-1-56-70
25. Influence of lipid composition of cationic liposomes 2X3-DOPE on mRNA delivery into eukaryotic cells
    Vysochinskaya* V., Shishlyannikov* S., Zabrodskaya* Y., Shmendel E., Klotchenko* S., Dobrovolskaya* O., Gavrilova* N., Makarova D., Plotnikova* M., Elpaeva* E., Gorshkov* A., Moshkoff* D., Maslov M., Vasin* A.
    Pharmaceutics — 2022. — Vol. 15. — Issue. 1. — pp. 8-
    DOI: 10.3390/pharmaceutics15010008
26. Influenza A Virus Causes Histopathological Changes and Impairment in Functional Activity of Blood Vessels in Different Vascular Beds
    Marchenko* V., Zelinskaya I., Toropova Y., Shmakova T., Podyacheva E., Lioznov* D., Zhilinskaya I.N.
    Viruses — 2022. — Vol. 14. — Issue. 2. — pp. 396-
    DOI: 10.3390/v14020396
27. Influenza A(H1N1)pdm09 Virus Alters Expression of Endothelial Factors in Pulmonary Vascular Endothelium in Rats
    Zhilinskaya* I., Lioznov* D., Amosova* I., Mukhametdinova D., Marchenko* V.
    Viruses — 2022. — Vol. 14. — Issue. 11. — pp. 2518-
    DOI: 10.3390/v14112518
28. Influenza B: Prospects for the Development of Cross-Protective Vaccines
    Tsybalova* L.M., Stepanova* L.A., Ramsay E.S., Vasin* A.V.
    Viruses — 2022. — Vol. 14. — Issue. 6. — pp. 1323-
    DOI: 10.3390/v14061323
29. Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22
    Melidou A., Ködmön C., Nahapetyan K., Kraus A., Alm E., Adlhoch C., Mooks P., Dave N., Carvalho C., Meslé M.M., Daniels R., Pebody R., Members of the WHO European Region influenza surveillance network (Tabain I., ..., Komissarov* A., Stolyarov* K., ..., Cottrell S.)
    Eurosurveillance — 2022. — Vol. 27. — Issue. 15. — pp. 2200255-
    DOI: 10.2807/1560-7917.ES.2022.27.15.2200255
30. Investigation of the morphology and electrical properties of graphene used in the development of biosensors for detection of influenza viruses
    Shmidt N.M., Usikov A.S., Shabunina E.I., Nashchekin A.V., Gushchina E.V., Eliseev I.A., Petrov V.N., Puzyk M.V., Avdeev O.V., Klotchenko* S.A., Lebedev S.P., Tanklevskaya E.M., Makarov* Y.N., Lebedev A.A., Vasin* A.V.
    Biosensors — 2022. — Vol. 12. — Issue. 1. — pp. 8-
    DOI: 10.3390/bios12010008
31. Luminescent polyelectrolytes with antiviral activity
    Panarin E.F., Fischer A.I., Nesterova N.A., Shtro* A.A., Dobrodumov A.V., Gavrilova I.I., Manakhov* V.A., Nekrasova T.N.
    Russian Chemical Bulletin — 2022. — Vol. 71. — Issue. 11. — pp. 2352-2357
    DOI: 10.1007/s11172-022-3662-4
32. Mechanism of Blood Vessel Damage in NonLethal Influenza Virus Infection in Experimental Animals
    Marchenko* V., Zhilinskaya* I.
    Developments in Clinical & Medical Pathology — 2022. — Vol. 2. — Issue. 2. — pp. -
    DOI: 10.31031/DCMP.2022.02.000533
33. Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection
    Zykova A.A., Blokhina E.A., Stepanova* L.A., Shuklina* M.A., Tsybalova* L.M., Kuprianov V.V., Ravin N.V.
    Nanomedicine: Nanotechnology, Biology and Medicine — 2022. — Vol. 39. — Issue. . — pp. 102463-
    DOI: 10.1016/j.nano.2021.102463
34. PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs
    Kuzmich* N., Andresyuk E., Porozov Y., Tarasov V., Samsonov M., Preferanskaya N., Veselov V., Alyautdin R.
    Molecules — 2022. — Vol. 27. — Issue. 2. — pp. 434-
    DOI: 10.3390/molecules27020434
35. Peripheral Blood Mononuclear Cell Cytokine mRNA Profiles in Acute Respiratory Infection Patients
    Plotnikova* M.A., Klotchenko* S.A., Lozhkov* A.A., Lebedev* K.I., Taraskin* A.S., Baranovskaya* I.L., Egorova* M.A., Ramsay* E.S., Chebotkevich V.N., Vasin* A.V.
    Journal of Global Infectious Diseases — 2022. — Vol. 14. — Issue. 4. — pp. 147-153
    DOI: 10.4103/jgid.jgid_301_21
36. Polymer complexes of rifampicin antibiotic based on poly(2-acrylamido-2-methylpropanesulfonic acid)
    Solovskii M.V., Borisenko M.S., Smirnova M.Yu., Eropkin* M.Yu., Eropkina* E.M., Tarabukina E.B.
    Prarmaceutical Chemistry Journal — 2022. — Vol. 56. — Issue. 8. — pp. 1041-1044
    DOI: 10.1007/s11094-022-02749-1
37. Preclinical Safety Evaluation: Acute and Repeated-Dose Toxicity of a New Intranasal Recombinant Vector Vaccine TB/FLU-04L Against Tuberculosis
    Stosman K., Sivak K., Aleksandrov A., Buzitskaya Z., Rassokha T., Stukova M.
    Drug Research — 2022. — Vol. 72. — Issue. 4. — pp. 215-219
    DOI: 10.1055/a-1771-5985
38. Protective effect of aminoguanidine against acute lung injury induced by influenza á(H1N1)pdm09 (mouseadapted) virus in mice with diabetes mellitus
    Aleksandrov* A.G., Savateeva-Lyubimova* T.N., Sivak* K.V., Stosman* K.I., Zhilinskaya* I.N.
    Journal of Research in Pharmacy — 2022. — Vol. 26. — Issue. 3. — pp. 523-533
    DOI: 10.29228/jrp.149
39. Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State
    Shtro* A.A., Petukhova* G.D., Romanova* A.S.
    Molecules — 2022. — Vol. 27. — Issue. 7. — pp. 2263-
    DOI: 10.3390/molecules27072263
40. Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter
    Sergeeva MV, Pulkina AA, Romanovskaya-Romanko EA, Mustafaeva AS, Egorov AY, Stukova MA.
    Applied Biochemistry and Microbiology — 2022. — Vol. 58. — Issue. 7. — pp. 878-886
    DOI: 10.1134/S0003683822070067
41. Reduced Amino Acid Alphabet-Based Encoding and Its Impact on Modeling Influenza Antigenic Evolution
    Forghani M., Firstkov A.L., Alyannezhadi M.M., Danilenko* D.M., Komissarov* A.B.
    Russian Journal of Infection and Immunity — 2022. — Vol. 12. — Issue. 5. — pp. 837-849
    DOI: 10.15789/2220-7619-RAA-1968
42. Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era
    Sominina* A., Danilenko* D., Komissarov* A., Karpova* L., Pisareva* M., Fadeev* A., Konovalova* N., Eropkin* M., Stolyarov* K., Shtro* A., Burtseva E., Lioznov* D.
    Viruses — 2022. — Vol. 14. — Issue. 9. — pp. 1909-
    DOI: 10.3390/v14091909
43. SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
    Vakhrusheva A.V., Kudriavtsev A.V., Kryuchkov N.A., Deev R.V., Frolova M.E., Blagodatskikh K.A., Djonovic M., Nedorubov A.A., Odintsova E., Ivanov A.V., Romanovskaya-Romanko* E.A., Stukova* M.A., Isaev A.A., Krasilnikov* I.V.
    — 2022. — Vol. 10. — Issue. 8. — pp. 1290-
    DOI: 10.3390/vaccines10081290
44. Simultaneous detection of RIG-1, MDA5, AND IFIT-1 expression is a convenient tool for evaluation of the interferon-mediated response
    Lozhkov* A.A., Plotnikova* M.A., Egorova* M.A., Baranovskaya* I.L., Elpaeva* E.A., Klotchenko* S.A., Vasin* A.V.
    Viruses — 2022. — Vol. 14. — Issue. 10. — pp. 2090-
    DOI: 10.3390/v14102090
45. Spread of endemic SARS-CoV-2 lineages in Russia before April 2021
    Klink G.V., Safina K.R., Garushyants S.K., Moldovan M., Nabieva E., Komissarov* A.B., Lioznov* D.A., Bazykin G.A., CoRGI (Coronavirus Russian Genetic Initiative) Consortium
    PLoS ONE — 2022. — Vol. 17. — Issue. 7. — pp. e0270717-
    DOI: 10.1371/journal.pone.0270717
46. Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia–A prospective cohort analysis
    Vetrova M., Lodi S., Rateau L., Patts G., Blokhina E., Palatkin V., Yaroslavtseva T., Toussova O., Bushara N., Bendiks S., Gnatienko N., Krupitsky E., Lioznov* D., Samet J., Lunze K.
    International Journal of Drug Policy — 2022. — Vol. 102. — Issue. . — pp. 103600-
    DOI: 10.1016/j.drugpo.2022.103600
47. Synthesis and evaluation of diterpenic Mannich bases as antiviral agents against influenza A and SARS-CoV-2
    Tretyakova E.V., Ma X., Kazakova O.B., Shtro* A.A., Petukhova* G.D., Klabukov* A.M., Dyatlov D.S., Smirnova A.A., Xu H., Xiao S.
    Phytochemistry Letters — 2022. — Vol. 51. — Issue. . — pp. 91-96
    DOI: 10.1016/j.phytol.2022.07.010
48. Synthesis, Phosphonylation, and Anti-Viral Activity of Some 6-Aryl-5-cyano-2-thiouracils
    Babushkina A.A., Piterskaya Yu. L., Shtro* A.A., Nikolaeva* Yu.V., Galochkina* A.V., Klabukov* A.M., Egorov D.M.
    Russian Journal of General Chemistry — 2022. — Vol. 92. — Issue. 1. — pp. 18-23
    DOI: 10.1134/S1070363222010042
49. The Rise and Spread of the SARS-CoV-2 AY.122 Lineage in Russia
    Klink G., Safina K., Nabieva E., Shvyrev N., Garushyants S., Alekseeva E.I., Komissarov* A., Danilenko* D., Pochtovyy A., Divisenko E., Vasilchenko L., Shidlovskaya E., Kuznetsova N., Speranskaya A., Samoilov A., Neverov A., Popova A., Fedonin G., Akimkin V., Lioznov* D., Gushchin V., Shchur V., Bazykin G.
    Virus Evolution — 2022. — Vol. . — Issue. . — pp. -
    DOI: 10.1093/ve/veac017
50. Toward a Home Test for COVID-19 Diagnosis: DNA Machine for Amplification-Free SARS-CoV-2 Detection in Clinical Samples
    El-Deeb A.A., Zablotskaya S.S., Rubel M.S., Nour M.A.Y., Kozlovskaya L.I., Shtro* A.A., Komissarov* A.B., Kolpashchikov D.M.
    ChemMedChem — 2022. — Vol. . — Issue. . — pp. -
    DOI: 10.1002/cmdc.202200382
51. Two Novel Lytic Bacteriophages Infecting Enterococcus spp. Are Promising Candidates for Targeted Antibacterial Therapy
    Tkachev P.V., Pchelin I.M., Azarov, D.V., Gorshkov* A.N., Shamova O.V., Dmitriev A.V., Goncharov A.E.
    Viruses — 2022. — Vol. 14. — Issue. 4. — pp. 831-
    DOI: 10.3390/v14040831
52. Unlocking capacities of genomics for the COVID-19 response and future pandemics
    Knyazev S., Pasaniuc B., Chhugani K., Deshpande D., Lu A., Sarwal V., Ayyala R., Singh H., Karthikeyan S., Knight R., Baykal P.I., Beerenwinkel N., Comarova Z., Smith A.L., Porozov Y., Vasylyeva T.I., Wertheim J.O., Tierney B.T., Mason C.E., Chiu C.Y., Sun R., Wu A., Abedalthagafi M.S., Pak V.M., Nagaraj S.H., Smith A.L., Skums P., Pasaniuc B., Komissarov* A., Mason C.E., Bortz E., Lemey P., Kondrashov F., Beerenwinkel N., Lam T.T., Wu N.C., Zelikovsky A., Knight R., Crandall K.A., Mangul S.
    Nature Methods — 2022. — Vol. 19. — Issue. 4. — pp. 374-380
    DOI: 10.1038/s41592-022-01444-z
53. Urinary Albumin-Creatinine Ratio and renal Function after Nephrectomy
    Popov S., Guseynov R., Sivak* K., Perepelitsa V., Katunin A., Zaitsev A.
    Kidney International Reports — 2022. — Vol. 7. — Issue. 2. — pp. 181-
    DOI: 10.1016/j.ekir.2022.01.425
54. VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
    Kulemzin S.V, Sergeeva* M.V., Baranov K.O., Gorchakov A.A., Guselnikov S.V., Belovezhets T.N., Volkova O.Yu., Najakshin A.M., Chikaev N.A., Danilenko* D.M., Taranin A.V.
    Journal of Personalized Medicine — 2022. — Vol. 12. — Issue. 6. — pp. 895-
    DOI: 10.3390/jpm12060895
55. òhylotravis: a new approach to visualization of the phylogenetic tree
    Forghani M., Vasev P.A., Bersenev A.Y., Bolkov M.A., Ramsay* E.S.
    Programming and Computer Software — 2022. — Vol. 48. — Issue. 3. — pp. 215-226
    DOI: 10.1134/S0361768822030045

Preprints:

1. An Early SARS-CoV-2 Omicron Outbreak in a Dormitory in Saint-Petersburg, Russia
   Klink G.V., Danilenko* D.M., Komissarov* A.B., Yolshin* N., Shneider* O.V., Shcherbak S, Nabieva E., Shvyrev N., Konovalova* N., Zheltukhina* A., Fadeev* A., Komissarova* K., Ksenafontov* A., Musaeva* T., Eder* V., Pisareva* M., Nekrasov* P., Shchur V., Bazykin G.A., Lioznov* D.A.
   medRxiv — 2022. — Vol. . — Issue. . — pp. -
   DOI: 10.1101/2022.11.23.22282648
2. IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine Against Respiratory Syncytial Virus Infection in Mice
   Pulkina* A.A., Vasilyev* K.A., Muzhikyan* A.A., Sergeeva* M.V., Romanovskaya-Romanko* E.A., Shurigina* A.ò.S., Vasin* A.V., Stukova* M.A., Egorov* A.
   Preprints with The Lancet — 2022. — Vol. . — Issue. . — pp. -
   DOI: 10.2139/ssrn.4205780

2021

RII authors are marked with an asterisk(*); — indexed by Scopus; — indexed by Web of Science.

1. 3-Cyanoazolo[5,1-c][1,2,4]triazines: synthesis and antiviral activity
   Sapozhnikova I.M., Ulomsky E.N., Rusinov V.L., Chupakhin O.N., Stepanov A.V., Savateeva-Lyubimova* T.N., Sivak* K.V.
   Chemistry of Heterocyclic Compounds — 2021. — Vol. 57. — Issue. 4. — pp. 467-472
   DOI: 10.1007/s10593-021-02925-3
2. Adaptation of Pseudomonas helmanticensis to fat hydrolysates and SDS: fatty acid response and aggregate formation
   Zubkov I.N., Nepomnyshchiy A.P., Kondratyev V.D., Sorokoumov P.N., Sivak* K.V., Ramsay* E.S., Shishlyannikov, S.M.
   Journal of Microbiology — 2021. — Vol. 59. — Issue. . — pp. 1104-1111
   DOI: 10.1007/s12275-021-1214-5
3. Age‑Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018–2019 Season
   Sominina* A., Danilenko* D., Komissarov* A., Pisareva* M., Musaeva* T., Bakaev* M., Afanasieva* O., Stolyarov* K., Smorodintseva* E., Rozhkova* E., Obraztsova* E., Dondurey* E., Guzhov* D., Timonina V., Golovacheva* E., Kurskaya O., Shestopalov A., Smirnova S., Alimov A., Lioznov* D.
   Journal of Epidemiology and Global Health — 2021. — Vol. . — Issue. . — pp. -
   DOI: 10.1007/s44197-021-00009-1
4. Antigenic and Genetic Characterization of Swine Influenza Viruses Identified in the European Region of Russia, 2014–2020
   Danilenko* D.M., Komissarov* A.B., Fadeev* A.V., Bakaev* M.I., Ivanova* A.A., Petrova* P.A., Vassilieva* A.D., Komissarova* K.S., Zheltukhina* A.I., Konovalova* N.I., Vasin* A.V.
   Frontiers in Microbiology — 2021. — Vol. 12. — Issue. . — pp. -
   DOI: 10.3389/fmicb.2021.662028
5. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
   Leneva I., Kartashova N., Poromov A., Gracheva A., Korchevaya E., Glubokova E., Borisova O., Shtro* A., Loginova S., Shchukina V., Khamitov R.
   Viruses — 2021. — Vol. 13. — Issue. 8. — pp. 1665-
   DOI: 10.3390/v13081665
6. Assessment of rat polyclonal antisera’s suitability in hemagglutination inhibition assay for influenza surveillance and antigenic mapping
   Danilenko* D.M., Eropkin* M.Y., Leonenko V.N., Konovalova* N.I., Petrova* P.A., Zheltukhina* A.I., Vassilieva* A.D.
   Journal of Virological Methods — 2021. — Vol. 293. — Issue. . — pp. 114170-
   DOI: 10.1016/j.jviromet.2021.114170
7. Clean And Folded: Production of Active, High Quality Recombinant Human Interferon-Λ1
   Shaldzhyan* A., Zabrodskaya* Y., Yolshin* N., Kudling, T., Lozhkov* A., Plotnikova* M., Ramsay* E., Taraskin* A., Nekrasov8 P., Grudinin* M., Vasin* A.
   Process Biochemistry — 2021. — Vol. 111. — Issue. 1. — pp. 32-36
   DOI: 10.1016/j.procbio.2021.08.029
8. Controlling the movement of magnetic iron oxide nanoparticles intended for targeted delivery of cytostatics
   Toropova Y., Korolev D., Istomina M., Shulmeyster G., Petukhov A., Mishanin V., Gorshkov* A., Podyacheva E., Gareev K., Bagrov A., Demidov O.
   International Journal of Nanomedicine — 2021. — Vol. 16. — Issue. . — pp. 5651-5664
   DOI: 10.2147/IJN.S318200
9. CRISPR-Cas9 mediated knockout of AnxA6 gene enhances influenza A virus replication in low-permissive HEK293FT cell line
   Komissarov* A., Sergeeva* M., Zhuravlev E., Medvedev S., Malakhova A., Andreeva E., Shurygina* A.P., Gorshkov* A., Timofeeva M., Balakhonova E., Grudinin* M., Zakian S., Richter V., Stepanov G.
   Gene — 2021. — Vol. 809. — Issue. . — pp. 146024-
   DOI: 10.1016/j.gene.2021.146024
10. Efficient synthesis and evaluation of antiviral and antitumor activity of novel 3-phosphonylated thiazolo[3,2-a]oxopyrimidines
    Babushkina A.A., Dogadina A.V., Egorov D.M., Piterskaia J.L., Shtro* A.A., Nikolaeva* Y.V., Galochkina* A.V., Kornev A.A., Boitsov V.M.
    Medicinal Chemistry Research — 2021. — Vol. 30. — Issue. . — pp. 2203-2215
    DOI: 10.1007/s00044-021-02801-x
11. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus
    Tsvetkov* V., Varizhuk A., Kozlovskaya L., Shtro* A., Lebedeva O., Komissarov* A., Vedekhina T., Manuvera V., Zubkova O., Eremeev A., Shustova E., Pozmogova G., Lioznov* D., Ishmukhametov A., Lazarev V., Lagarkova M.
    Biochimie — 2021. — Vol. 191. — Issue. . — pp. 27-32
    DOI: j.biochi.2021.08.003
12. Enhancement of the local cd8+ t-cellular immune response to mycobacterium tuberculosis in bcg-primed mice after intranasal administration of influenza vector vaccine carrying tb10.4 and hspx antigens
    Vasilyev* K., Shurygina* A.P., Zabolotnykh N., Sergeeva* M., Romanovskaya-Romanko* E., Pulkina* A., Buzitskaya* J., Dogonadze M.Z., Vinogradova T.I. Stukova* M.A.
    Vaccines — 2021. — Vol. 9. — Issue. 11. — pp. 1273-
    DOI: 10.3390/vaccines9111273
13. Evaluation of the diuretic effect of crude ethanol and saponin-rich extracts of Herniaria glabra L. in rats
    Hakim, E.M. Sivak* K.V., Kaukhova I.E.
    Journal of Ethnopharmacology — 2021. — Vol. 273. — Issue. . — pp. 113942-
    DOI: 10.1016/j.jep.2021.113942
14. Evaluation of the performance of SARSCoV2 antibody assays for the longitudinal populationbased study of COVID19 spread in St. Petersburg, Russia: Interpretation
    Barchuk A., Shirokov D., Sergeeva* M., Tursun­zade R., Dudkina O., Tychkova V., Barabanova L., Skougarevskiy D., Danilenko* D.
    Journal of Medical Virology — 2021. — Vol. 93. — Issue. 10. — pp. 5846-5852
    DOI: 10.1002/jmv.27126
15. Extracellular vesicles in viral pathogenesis: A case of Dr. Jekyll and Mr. Hyde
    Purvinsh* L., Gorshkov* A., Brodskaia* A., Vasin* A.
    Life — 2021. — Vol. 11. — Issue. 1. — pp. 45-
    DOI: 10.3390/life11010045
16. Fast prototyping of a local fuzzy search system for decision support and retraining of hospital staff during pandemic
    Bakin E.A., Stanevich O.V., Danilenko* D.M., Lioznov* D.A., Kulikov A.N.
    Health Information Science and Systems — 2021. — Vol. 9. — Issue. 1. — pp. 1-9
    DOI: 10.1007/s13755-021-00150-y
17. Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia
    Komissarov* A.B., Safina K.R., Garushyants S.K., Fadeev* A.V., Sergeeva* M.V., Ivanova* A.A., Danilenko* D.M., Lioznov* D.A., Shneider O.V., Shvyrev N., Spirin V., Glyzin D., Shchur V. & Bazykin G.A.
    Nature Communications — 2021. — Vol. 12. — Issue. 1. — pp. 1-13
    DOI: 10.1038/s41467-020-20880-z
18. Graphene on sic substrate as biosensor: Theoretical background, preparation, and characterization
    Lebedev A.A., Davydov S.Y., Eliseyev I.A., Roenkov A.D., Avdeev O., Lebedev S.P., Makarov Y., Puzyk M., Klotchenko* S. and Usikov A.S.
    Materials — 2021. — Vol. 14. — Issue. 3. — pp. 1-24
    DOI: 10.3390/ma14030590
19. Hemolytic activity, cytotoxicity, and antimicrobial effects of human albumin-and polysorbate-80-coated silver nanoparticles
    Korolev D., Shumilo M., Shulmeyster G., Krutikov A., Golovkin A., Mishanin A., Gorshkov* A., Spiridonova A., Domorad A., Krasichkov A., Galagudza, M.
    Nanomaterials — 2021. — Vol. 11. — Issue. 6. — pp. 1484-
    DOI: 10.3390/nano11061484
20. Highly Pathogenic Avian Influenza A(H5N8) Virus Clade 2.3.4.4b, Western Siberia, Russia, 2020
    Sobolev I., Sharshov K., Dubovitskiy N., Kurskaya O., Alekseev A., Leonov S., Yushkov Y., Irza V., Komissarov* A., Fadeev* A., Danilenko* D., Mine J., Tsunekuni R., Uchida Y., Saito T., Shestopalov A.
    Emerging Infectious Diseases — 2021. — Vol. 27. — Issue. 8. — pp. 2221-
    DOI: 10.3201/eid2708.204969
21. HIV and Substance Use Stigma, Intersectional Stigma and Healthcare Among HIV-Positive PWID in Russia
    Vetrova M.V., Cheng D.M., Bendiks S., Gnatienko N., Lloyd-Travaglini C., Jiang W., Luoma J., Blokhina E., Krupitsky E., Lioznov* D., Ekstrand M.L., Raj A., Samet J.H., Lunze K.
    AIDS and Behavior — 2021. — Vol. . — Issue. . — pp. 1-12
    DOI: 10.1007/s10461-021-03172-5
22. IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses
    Plotnikova* M., Lozhkov* A., Romanovskaya-Romanko* E., Baranovskaya* I., Sergeeva* M., Klotchenko* S., Vasin* A.
    Viruses — 2021. — Vol. 13. — Issue. 8. — pp. 1602-
    DOI: 10.3390/v13081602
23. Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.
    Vasilyev* K., Shurygina* A.-P., Sergeeva* M., Stukova* M., Egorov* A.
    Microorganisms — 2021. — Vol. 9. — Issue. 4. — pp. 690-
    DOI: 10.3390/microorganisms9040690
24. Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics
    Dukhinova M., Kokinos E., Kuchur P., Komissarov A., Shtro* A.
    Cytokine & Growth Factor Reviews — 2021. — Vol. 59. — Issue. . — pp. 46-61
    DOI: 10.1016/j.cytogfr.2020.11.003
25. Modifications of isoalantolactone leading to effective anti-bacterial and anti-viral compounds
    Patrushev S.S., Burova L.G., Shtro* A.A., Rybalova T.V., Baev D.S., Shirokikh I.Y.V., Evstropov A.N., Shults E.E.
    Letters in Drug Design & Discovery — 2021. — Vol. 18. — Issue. 7. — pp. -
    DOI: 10.2174/1570180817999201211193151
26. Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs
    Sergeeva* M., Romanovskaya-Romanko* E., Zabolotnyh* N., Pulkina* A., Vasilyev* K., Shurigina* A.-P., Buzitskaya* J., Zabrodskaya* Y., Fadeev* A., Vasin* A., Vinogradova* T.I., Stukova* M.A.
    Vaccines — 2021. — Vol. 9. — Issue. 4. — pp. 394-
    DOI: 10.3390/vaccines9040394
27. Mutations designed to modify the NS gene mRNA secondary structure affect influenza A pathogenicity in vivo
    Baranovskaya* I.L., Sergeeva* M.V., Taraskin* A.S., Lozhkov* A.A., Vasin* A.V.
    Microbiology Independent Research Journal (MIR Journal) — 2021. — Vol. 8. — Issue. 1. — pp. 1-9
    DOI: 10.18527/2500-2236-2021-8-1-1-9
28. Neutralizing activity of sera from sputnik v-vaccinated people against variants of concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow endemic SARS-CoV-2 variants
    Gushchin V.A., Dolzhikova I.V., Shchetinin A.M., Odintsova A.S., Siniavin A.E., Nikiforova M.A., Pochtovyi A.A., Shidlovskaya E.V., Kuznetsova N.A., Burgasova O.A., Kolobukhina L.V., Iliukhina A.A., Kovyrshina A.V., Botikov A.G., Kuzina A.V., Grousova D.M., Tukhvatulin A.I., Shcheblyakov D.V., Zubkova O.V., Karpova O.V., Voronina O.L., Ryzhova N.N., Aksenova E.I., Kunda M.S., Lioznov* D.A., Danilenko* D.M., Komissarov* A.B., Tkachuck A.P., Logunov D.Y., Gintsburg A.L.
    Vaccines — 2021. — Vol. 9. — Issue. 7. — pp. -
    DOI: 10.3390/vaccines9070779
29. Neutron Scattering Techniques and Complementary Methods for Structural and Functional Studies of Biological Macromolecules and Large Macromolecular Complexes
    Lebedev D.V., Egorov* V.V., Shvetsov A.V., Zabrodskaya* Y.A., Isaev-Ivanov V.V., Konevega A.L.
    Crystallography Reports — 2021. — Vol. 66. — Issue. 2. — pp. 242-253
    DOI: 10.1134/s1063774521020103
30. New heteroanalogs of tricyclic ascidian alkaloids: Synthesis and biological activity
    Goryaeva M.V., Kushch S.O., Burgart Y.V., Ezhikova M.A., Kodess M.I., Slepukhin P.A., Triandafilova G.A., Krasnykh O.P., Yakovleva E.I., Zarubaev V.V., Sinegubova E.O., Esaulkova I.L., Shtro* A.A., Galochkina* A.V., Nikolaeva* Y.V., Saloutin V.I.
    Organic and Biomolecular Chemistry — 2021. — Vol. 19. — Issue. 45. — pp. 9925-9935
    DOI: 10.1039/d1ob01843d
31. Old dog, new tricks: Influenza A virus NS1 and in vitro fibrillogenesis
    Shaldzhyan* A.A., Zabrodskaya* Y.A., Baranovskaya* I.L., Sergeeva* M.V., Gorshkov* A.N., Savin* I.I., Shishlyannikov* S.M., Ramsay* E.S., Protasov* A.V., Kukhareva* A.P. Egorov* V.V.
    Biochimie — 2021. — Vol. 190. — Issue. . — pp. 50-56
    DOI: 10.1016/j.biochi.2021.07.005
32. Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses
    Kozlovskaya L.I., Volok V.P., Shtro* A.A., Nikolaeva* Y.V., Chistov A.A., Matyugina E.S., Belyaev E.S., Jegorov A.V., Snoeck R., Korshun V.A., Graciela A., Osolodkin D., Ishmukhametov A., Aralov A.
    European Journal of Medicinal Chemistry — 2021. — Vol. 220. — Issue. . — pp. 113467-
    DOI: 10.1016/j.ejmech.2021.113467
33. Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 40-O-(2-Fluoroethyl) Moiety and the Potential of Their 18F-Labeled Derivatives for Neuroinflammation Imaging
    Vaulina D.D., Stosman* K.I., Sivak* K.V., Aleksandrov* A.G., Viktorov N.B., Kuzmich* N.N., Kiseleva M.M., Kuznetsova O.F., Gomzina, N.A.
    Molecules — 2021. — Vol. 26. — Issue. 21. — pp. 6630-
    DOI: 10.3390/molecules26216630
34. Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus
    Sokolova A.S., Yarovaya O.I., Baranova D.V., Galochkina* A.V., Shtro* A.A., Kireeva M.V., Borisevich S.S., Gatilov Y.V., Zarubaev V.V., Salakhutdinov, N.F.
    Archives of Virology — 2021. — Vol. 166. — Issue. . — pp. 1965-1976
    DOI: 10.1007/s00705-021-05102-1
35. Quench me if you can: Alpha-2-macroglobulin trypsin complexes enable serum biomarker analysis by MALDI mass spectrometry
    Taraskin* A.S., Semenov K.K., Protasov* A.V., Lozhkov* A.A., Tyulin* A.A., Shaldzhyan* A.A., Ramsay* E.S., Mirgorodskaya* O.A., Klotchenko* S.A. and Zabrodskaya* Y.A.
    Biochimie — 2021. — Vol. 185. — Issue. . — pp. 87-95
    DOI: 10.1016/j.biochi.2021.03.005
36. Respiratory Syncytial Virus G Protein Sequence Variability among Isolates from St. Petersburg, Russia, during the 2013-2014 Epidemic Season
    Krivitskaya* V., Komissarova* K., Pisareva* M., Sverlova M., Fadeev* A., Petrova* E., Timonina V., Sominina* A., Danilenko* D.
    Viruses — 2021. — Vol. 13. — Issue. 1. — pp. 119-
    DOI: 10.3390/v13010119
37. Rosin derivatives as a platform for the antiviral drug design
    Popova L., Ivanchenko O., Pochkaeva E., Klotchenko S., Plotnikova M., Tsyrulnikova A., Aronova E.
    Molecules — 2021. — Vol. 26. — Issue. 13. — pp. 3836-
    DOI: 10.3390/molecules26133836
38. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
    Zakarya K., Kutumbetov L., Orynbayev M., Abduraimov Y., Sultankulova K., Kassenov M., Sarsenbayeva G., Kulmagambetov I., Davlyatshin T., Sergeeva* M., Stukova* M.
    EClinicalMedicine — 2021. — Vol. 36. — Issue. . — pp. 101078-
    DOI: doi.org/10.1016/j.eclinm.2021.101078
39. The Global Epidemiology of RSV in Community and Hospitalized Care: Findings from 15 Countries
    Staadegaard L., Caini S., Wangchuk S., Thapa B., De Almeida W.A.F., De Carvalho F.C., Njouom R., Fasce R.A., Bustos P., Kyncl J., Novakova L., Caicedo A.B., De Mora Coloma D.J., Meijer A., Hooiveld M., Huang S., Wood T., Guiomar R., Rodrigues A.P., Danilenko* D., Stolyarov* K., Lee V.J.M., Ang L.W., Cohen C., Moyes J., Larrauri A., Delgado-Sanz C., Le M.Q., Hoang P.V.M., Demont C., Bangert M., Van Summeren J., Dückers M., Paget J.
    Open Forum Infectious Diseases — 2021. — Vol. 8. — Issue. 7. — pp. -
    DOI: 10.1093/ofid/ofab159
40. The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia
    Corcorran M.A., Ludwig-Baron N., Cheng D.M., Lioznov* D., Gnatienko N., Patts G., So-Armah K., Blokhina E., Bendiks S., Krupitsky E., Samet J.H., Tsui J.I.
    AIDS and Behavior — 2021. — Vol. . — Issue. . — pp. 1-9
    DOI: 10.1007/s10461-021-03214-y
41. Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge
    Mezhenskaya D., Isakova-Sivak I., Matyushenko V., Donina S., Rekstin A., Sivak* K., Yakovlev* K., Katelnikova A., Kryshen K., Makarov V., Rudenko L.
    Viruses — 2021. — Vol. 13. — Issue. 7. — pp. 1280-
    DOI: 10.3390/v13071280
42. Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021
    Adlhoch C., Mook P., Lamb F., Ferland L., Melidou A., Amato-Gauci A. J., Pebody R., the European Influenza Surveillance Network (…, Sominina* A., Danilenko* D., ...)
    Eurosurveillance — 2021. — Vol. 26. — Issue. 11. — pp. -
    DOI: 10.2807/1560-7917.ES.2021.26.11.2100221

2020

RII authors are marked with an asterisk(*).

1. 5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses
   Nikolayeva* Y V, Ulashchik E A, Chekerda* E V, Galochkina* A V, Slesarchuk N A, Chistov A A, Nikitin T D, Korshun V A, Shmanai V V, Ustinov A V, Shtro* A A
   Russian Journal of Bioorganic Chemistry — 2020. — Vol. 46. — Issue. 3. — pp. 315-320
   DOI: 10.1134/S1068162020030139
2. A highly efficient and safe gene delivery platform based on polyelectrolyte core-shell nanoparticles for hard-to-transfect clinically relevant cell types
   Tarakanchikova Yana, Muslimov Albert, Sergeev Igor, Lepik Kirill, Yolshin* Nikita, Goncharenko Alexander, Vasilyev* Kirill, Eliseev Igor, Bukatin Anton, Sergeev Vladislav, Pavlov Sergey, Popov Alexey, Meglinski Igor, Afanasiev Boris, Parakhonskiy Bogdan, Sukhorukov Gleb, Gorin Dmitry
   Journal of Materials Chemistry B — 2020. — Vol. 8. — Issue. 41. — pp. 9576-9588
   DOI: 10.1039/d0tb01359e
3. A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
   Kiseleva Irina, Isakova-Sivak Irina, Stukova* Marina, Erofeeva* Marianna, Donina Svetlana, Larionova Natalie, Krutikova Elena, Bazhenova Ekaterina, Stepanova* Ekaterina, Vasilyev* Kirill, Matyushenko Victoria, Krylova Marina, Galatonova Julia, Ershov Aleksey, Lioznov* Dmitry, Sparrow Erin Grace, Torelli Guido, Rudenko Larisa
   Vaccines — 2020. — Vol. 8. — Issue. 2. — pp. -
   DOI: 10.3390/vaccines8020296
4. A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles
   Mardanova Eugenia S, Takova Katerina H, Toneva Valentina T, Zahmanova Gergana G, Tsybalova* Liudmila M, Ravin Nikolai V
   Biotechnology Letters — 2020. — Vol. 42. — Issue. 11. — pp. 2441-2446
   DOI: 10.1007/s10529-020-02995-x
5. Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018
   Mook Piers, Meerhoff Tamara, Olsen Sonja J, Snacken Rene, Adlhoch Cornelia, Pereyaslov Dmitriy, Broberg Eeva K, Melidou Angeliki, Brown Caroline, Penttinen Pasi, Collective of the WHO European Region European Influenza Surveillance Network (…, Sominina* Anna A.,...)
   Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 2. — pp. 150-161
   DOI: 10.1111/irv.12703
6. Antibody microarray immunoassay for screening and differential diagnosis of upper respiratory tract viral pathogens
   Plotnikova* Marina A., Klotchenko* Sergey A., Lebedev* Kirill, I, Lozhkov* Alexey A., Taraskin* Aleksandr S., Gyulikhandanova* Natalia E., Ramsay* Edward S., Vasin* Andrey V.
   Journal of Immunological Methods — 2020. — Vol. 478. — Issue. . — pp. -112712
   DOI: 10.1016/j.jim.2019.112712
7. Antiviral activity of amides and carboxamides of quinolizidine alkaloid (-)-cytisine against human influenza virus A (H1N1) and parainfluenza virus type 3
   Fedorova* Victoria A., Kadyrova* Renata A., Slita Alexander V, Muryleva Anna A., Petrova Polina R., Kovalskaya Alena V, Lobov Alexander N., Zileeva Zulfiya R., Tsypyshev Dmiry O., Borisevich Sophia S., Tsypysheva Inna P., Vakhitova Julia V., Zarubaev Vladimir V.
   Natural Product Research — 2020. — Vol. . — Issue. . — pp. 1-9
   DOI: 10.1080/14786419.2019.1696791
8. Cold and distant: structural features of the nucleoprotein complex of a cold-adapted influenza A virus strain
   Shvetsov A V, Lebedev D V, Zabrodskaya* Y A, Shaldzhyan* A A, Egorova* M A, Vinogradova D S, Konevega A L, Gorshkov* A N, Ramsay* E S, Radulescu A, Sergeeva* M V, Plotnikova* M A, Komissarov* A B, Taraskin* A S, Lebedev* K I, Garmay Yu P, Kuznetsov* V V, Isaev-Ivanov V V, Vasin* A V, Tsybalova* L M, Egorov* V V
   Journal of Biomolecular Structure & Dynamics — 2020. — Vol. . — Issue. . — pp. 1-10
   DOI: 10.1080/07391102.2020.1776636
9. Complicated hospitalization due to influenza: results from the Global Hospital Influenza Networkfor the 2017-2018 season
   Lina Bruno, Georges Alexandre, Burtseva Elena, Nunes Marta C, Andrew Melissa K, McNeil Shelly A, Ruiz-Palacios Guillermo M, Feng Luzhao, Kyncl Jan, Vanhems Philippe, Ortiz Justin R, Paget John, Reiner Robert C, on behalf of the GIHSN 2017–2018 study collaborators (..., Sominina* Anna,...)
   BMC Infectious Diseases — 2020. — Vol. 20. — Issue. 1. — pp. 465-
   DOI: 10.1186/s12879-020-05167-4
10. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses
    Matyushenko Victoria, Kotomina Tatiana, Kudryavtsev Igor, Mezhenskaya Daria, Prokopenko Polina, Matushkina Anastasia, Sivak* Konstantin, Muzhikyan* Arman, Rudenko Larisa, Isakova-Sivak Irina
    Antiviral Research — 2020. — Vol. 182. — Issue. . — pp. 104864-
    DOI: 10.1016/j.antiviral.2020.104864
11. Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia
    Gnatienko Natalia, Lioznov* Dmitry, Raj Anita, Blokhina Elena, Rosen Sydney, Cheng Debbie M., Lunze Karsten, Bendiks Sally, Truong Ve, Bushara Natalia, Toussova Olga, Quinn Emily, Krupitsky Evgeny, Samet Jeffrey H.
    Addiction Science & Clinical Practice — 2020. — Vol. 15. — Issue. 1. — pp. -1
    DOI: 10.1186/s13722-020-0179-8
12. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial
    Freiberg Matthew S, Cheng Debbie M, Gnatienko Natalia, Blokhina Elena, Coleman Sharon M, Doyle Margaret F, Yaroslavtseva Tatiana, Bridden Carly, So-Armah Kaku, Tracy Russell, Bryant Kendall, Lioznov* Dmitry, Krupitsky Evgeny, Samet Jeffrey H
    JAMA Network Open — 2020. — Vol. 3. — Issue. 5. — pp. e204330-
    DOI: 10.1001/jamanetworkopen.2020.4330
13. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis
    Nurbubu T. Moldogazieva, Daria S. Ostroverkhova, Nikolai N. Kuzmich*, Vladimir V. Kadochnikov, Alexander A. Terentiev and Yuri B. Porozov
    International Journal of Molecular Sciences. — 2020. — Vol. 21. — Issue. 3. — pp. 893-
    DOI: 10.3390/ijms21030893
14. Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model
    Prokopyeva Elena, Kurskaya Olga, Sobolev Ivan, Solomatina Mariia, Murashkina Tatyana, Suvorova Anastasia, Alekseev Alexander, Danilenko* Daria, Komissarov* Andrey, Fadeev* Artem, Ramsay* Edward, Shestopalov Alexander, Dygai Alexander, Sharshov Kirill
    Viruses — 2020. — Vol. 12. — Issue. 4. — pp. -
    DOI: 10.3390/v12040470
15. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
    Alm Erik, Broberg Eeva K, Connor Thomas, Hodcroft Emma B, Komissarov* Andrey B, Maurer-Stroh Sebastian, Melidou Angeliki, Neher Richard A, O'Toole Aine, Pereyaslov Dmitriy
    Euro Surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin — 2020. — Vol. 25. — Issue. 32. — pp. -
    DOI: 10.2807/1560-7917.ES.2020.25.32.2001410
16. Human respiratory syncytial virus and influenza seasonality patterns—Early findings from the WHO global respiratory syncytial virus surveillance
    Mandeep Chadha, Siddhivinayak Hirve, Christina Bancej, Ian Barr, Elsa Baumeister, Braulia Caetano, Malinee Chittaganpitch, Badarch Darmaa, Joanna Ellis, Rodrigo Fasce, Herve Kadjo, Sandra Jackson, Vivian Leung, Maria Pisareva*, Jocelyn Moyes, Amel Naguib, Almiro Tivane, Wenqing Zhang, On behalf of the WHO RSV Surveillance Group (..., Elizaveta Smorodintseva*,...)
    Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 6. — pp. 638-646
    DOI: 10.1111/irv.12726
17. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption-an observational cross-sectional study
    So-Armah Kaku, Freiberg Matthew, Cheng Debbie, Lim Joseph K., Gnatienko Natalia, Patts Gregory, Doyle Margaret, Fuster Daniel, Lioznov* Dmitry, Krupitsky Evgeny, Samet Jeffrey
    BMC Gastroenterology — 2020. — Vol. 20. — Issue. 1. — pp. -1
    DOI: 10.1186/s12876-019-1136-4
18. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections
    Klausberger Miriam, Leneva Irina A., Egorov* Andrey, Strobl Florian, Ghorbanpour Sahar M., Falynskova Irina N., Poddubikov Alexander, V, Makhmudova Nailya R., Krokhin Artem, Svitich Oxana A., Grabherr Reingard
    Vaccine — 2020. — Vol. 38. — Issue. 4. — pp. 859-867
    DOI: 10.1016/j.vaccine.2019.10.083
19. Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin
    Elena A. Blokhina, Eugenia S. Mardanova, Liudmila A. Stepanova*, Liudmila M. Tsybalova* and Nikolai V. Ravin
    Plants — 2020. — Vol. 9. — Issue. 2. — pp. 162-
    DOI: 10.3390/plants9020162
20. Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study
    Uuskula Anneli, Vickerman Peter, Raag Mait, Walker Josephine, Paraskevis Dimitrios, Eritsyan Ksenia, Sypsa Vana, Lioznov* Dmitry, Avi Radko, Des Jarlais Don
    PloS One — 2020. — Vol. 15. — Issue. 10. — pp. e0240224-
    DOI: 10.1371/journal.pone.0240224
21. Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections
    Isakova-Sivak Irina, Matyushenko Victoria, Stepanova Ekaterina, Matushkina Anastasia, Kotomina Tatiana, Mezhenskaya Daria, Prokopenko Polina, Kudryavtsev Igor, Kopeykin Pavel, Sivak* Konstantin, Rudenko Larisa
    Vaccines — 2020. — Vol. 8. — Issue. 2. — pp. -
    DOI: 10.3390/vaccines8020196
22. Replicative senescence in MSCWJ-1 human umbilical cord mesenchymal stem cells is marked by characteristic changes in motility, cytoskeletal organization, and RhoA localization
    Bobkov* Danila, Polyanskaya Anastasia, Musorina Anastasia, Lomert Ekaterina, Shabelnikov Sergey, Poljanskaya Galina
    Molecular biology reports — 2020. — Vol. 47. — Issue. 5. — pp. 3867-3883
    DOI: 10.1007/s11033-020-05476-6
23. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17
    Jackson Sandra, Peret Teresa C T, Ziegler Thedi T, Thornburg Natalie J, Besselaar Terry, Broor Shobha, Barr Ian, Baumeister Elsa, Chadha Mandeep, Chittaganpitch Malinee, Darmaa Badarch, Ellis Joanna, Fasce Rodrigo, Herring Belinda, Herve Kadjo, Hirve Siddhivinayak, Li Yan, Pisareva* Maria, Moen Ann, Naguib Amel, Palekar Rakhee, Potdar Varsha, Siqueira Marilda, Treurnicht Florette, Tivane Almiro, Venter Marietjie, Wairagkar Niteen, Zambon Maria, Zhang Wenqing
    Influenza and Other Respiratory Viruses — 2020. — Vol. 14. — Issue. 6. — pp. 671-677
    DOI: 10.1111/irv.12771
24. Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
    Sarsenbayeva Gulbanu, Issagulov Timur, Kassenov Markhabat, Abitay Ruslan, Orynbayev Mukhit, Stukova* Marina, Pisareva* Maria, Davlyatshin Timur, Kutumbetov Lespek, Khairullin Berik
    Human Vaccines & Immunotherapeutics — 2020. — Vol. 16. — Issue. 8. — pp. 1791-1797
    DOI: 10.1080/21645515.2019.1705691
25. The Effect of TLR4 Blockade on Some Indicators of Systemic Inflammatory Response to Proteus mirabilis LPS in Rats
    Sivak* K V, Stosman* K I, Rassokha* T A, Aleksandrov* A G, Kuzmich* N N, Orshanskaya* Ya R, Savateeva-Lubimova* T N, Lesiovskaya* E E
    Bulletin of Experimental Biology and Medicine — 2020. — Vol. 169. — Issue. 6. — pp. 795-797
    DOI: 10.1007/s10517-020-04981-9
26. The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
    Volobueva Alexandrina, Egorova Anna, Galochkina* Anastasia, Ekins Sean, Zarubaev Vladimir, Makarov Vadim
    Molecules — 2020. — Vol. 25. — Issue. 6. — pp. -
    DOI: 10.3390/molecules25061345
27. Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats
    Shekunova Elena V., Kashkin Vladimir A., Muzhikyan* Arman A., Makarova Marina N., Balabanyan Vadim Y., Makarov Valery G.
    European Journal of Pharmacology — 2020. — Vol. 866. — Issue. . — pp. -172835
    DOI: 10.1016/j.ejphar.2019.172835
28. Time machine: Can a dye from 1928 be re-purposed for modern, fluorescence-based detection of amyloid-like fibrils?
    Antimonova O.I, Grudinina N.A., Egorov* V.V., Ilyin V.V., Zabrodskaya* Y.A., Ramsay* E.S., Shabalin K.A., Protasov* A., V, Yakimov A.P., Polukeev V.A., Shavlovsky M.M.
    Dyes and Pigments — 2020. — Vol. 172. — Issue. . — pp. -107863
    DOI: 10.1016/j.dyepig.2019.107863
29. Ultrastructural Changes in the Air-Blood Barrier of Rats in Acute Intoxication with Furoplast Pyrolysis Products
    Tolkach P G, Basharin V A, Chepur S V, Gorshkov* A N, Sizova D T
    Bulletin of Experimental Biology and Medicine — 2020. — Vol. 169. — Issue. 2. — pp. 270-275
    DOI: 10.1007/s10517-020-04866-x

2019

RII authors are marked with an asterisk(*).

1. A double-edged sword: supramolecular complexes of triazavirine display multicenter binding effects which influence aggregate formation
   Zabrodskaya* Yana A., Shvetsov Alexey V., Tsvetkov* Vladimir B., Egorov* Vladimir V.
   Journal of Biomolecular Structure & Dynamics — 2019. — Vol. 37. — Issue. 12. — pp. 3041-3047
   DOI: 10.1080/07391102.2018.1507837
2. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care
   Samet JH, Blokhina E, Cheng DM, Walley AY, Lioznov* D, Gnatienko N, Quinn EK, Bridden C, Chaisson CE, Toussova O, Gifford AL, Raj A, Krupitsky E.
   AIDS — 2019. — Vol. 33. — Issue. 9. — pp. 1467-1476
   DOI: 10.1097/QAD.0000000000002230
3. Absolute Quantitation of Proteins by Acid Hydrolysis Combined With Amino Acid Detection by Mass Spectrometry
   Mirgorodskaya* O.A., Körner R., Kozmin Y.P., Roepstorff P.
   Amino Acid Analysis — 2019. — Vol. 2030. — Issue. . — pp. 11-16
   DOI: 10.1007/978-1-4939-9639-1_2
4. Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies
   Mitrofanova L.B., Vorobeva O.M., Gorshkov* A.N.
   Oncotarget — 2019. — Vol. 10. — Issue. 3. — pp. 289-312
   DOI: 10.18632/oncotarget.26513
5. Approval of the method of electrophoretic separation and identification of some urine proteins in rats with toxic nephropathy (English abstract only)
   Sivak* K.V., Zabrodskaya* Ya.A., Dobrovolskaya* O.A.
   Medical Academic Journal — 2019. — Vol. . — Issue. . — pp. -
   DOI: 10.17816/MAJ19371-82
6. Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV-The Russia ARCH Observational Study
   So-Armah KA, Cheng DM, Freiberg MS, Gnatienko N, Patts G, Ma Y, White L, Blokhina E, Lioznov* D, Doyle MF, Tracy RP, Chichetto N, Bridden C, Bryant K, Krupitsky E, Samet JH.
   PLoS One — 2019. — Vol. 14. — Issue. 8. — pp. -
   DOI: 10.1371/journal.pone.0219710
7. Benzothiazole-based cyanines as fluorescent light-up probes for duplex and quadruplex DNA
   Turaev Anton V., Tsvetkov* Vladimir B., Tankevich Maria V, Smirnov Igor P., Aralov Andrey V, Pozmogova Galina E., Varizhuk Anna M.
   Biochimie — 2019. — Vol. 162. — Issue. . — pp. 216-228
   DOI: 10.1016/j.biochi.2019.04.018
8. Biological Kerker Effect Boosts Light Collection Efficiency in Plants
   Barhom Hani, Machnev Andrey A., Noskov Roman E., Goncharenko* Alexander, Gurvitz Egor A., Timin Alexander S., Shkoldin Vitaliy A., Koniakhin Sergei V., Koval Olga Yu., Zyuzin Mikhail V., Shalin Alexander S., Shishkin Ivan I., Ginzburg Pavel
   Nano Letters — 2019. — Vol. 19. — Issue. 10. — pp. 7062-7071
   DOI: 10.1021/acs.nanolett.9b02540
9. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats
   Fedorova Olga V., Fadeev* Artem V., Grigorova Yulia N., Marshall Courtney A., Zernetkina Valentina, Kolodkin Nikolai I., Agalakova Natalia I., Konradi Alexandra O., Lakatta Edward G., Bagrov Alexei Y.
   Journal of Cardiovascular Pharmacology — 2019. — Vol. 74. — Issue. 5. — pp. 436-442
   DOI: 10.1097/FJC.0000000000000730
10. Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection
    Baranovskaya* Irina, Sergeeva* Mariia, Fadeev* Artem, Kadirova* Renata, Ivanova* Anna, Ramsay* Edward, Vasin* Andrey
    Virology Journal — 2019. — Vol. 16. — Issue. 1. — pp. -162
    DOI: 10.1186/s12985-019-1271-0
11. Changing times: Fluorescence-lifetime analysis of amyloidogenic SF-IAPP fusion protein
    Antimonova Olga I., Lebedev Dmitry V., Zabrodskaya* Yana A., Grudinina Natalia A., Timkovsky Andrey L., Ramsay Edward, Shavlovsky Michael M., Egorov* Vladimir V.
    Journal of Structural Biology — 2019. — Vol. 205. — Issue. 1. — pp. 78-83
    DOI: 10.1016/j.jsb.2018.11.006
12. Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot
    Siddhivinayak Hirve, Nigel Crawford, Rakhee Palekar, Wenqing Zhang on behalf of the WHO RSV surveillance Group (…, Maria Pisareva*, Elizaveta Smorodintseva*, …)
    Influenza and Other Respiratory Viruses — 2019. — Vol. . — Issue. . — pp. 1-11
    DOI: 10.1111/irv.12688
13. Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019
    Segaloff H., Melidou A., Adlhoch C., Pereyaslov D., Emmanuel Robesyn E., Penttinen P., Olsen S.J., WHO European Region and the European Influenza Surveillance Network (…, Anna Sominina* and Elena Burtseva, …)
    Eurosurveillance — 2019. — Vol. 24. — Issue. 9. — pp. 1-8
    DOI: 10.2807/1560.7917.ES.2019.24.9.1900125
14. Comparative Efficacy and Safety of Preventive Treatment With Cytovir-3 and Arbidol in Children During Seasonal Outbreak of Respiratory Viral Infection (An Open-Label Randomized Clinical Study)
    Smirnov V.S., Savelyev S.A., Petlenko S.V., Redlich G., Erofeeva* M.K., Lyovina A.V., Zaviyalova N.I.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 2. — pp. 273-278
    DOI: 10.15789/2220-7619-2019-2-273-278
15. Diels-Alder adducts of 3-N-substituted derivatives of (-)-Cytisine as influenza A/H1N1 virus inhibitors; stereodifferentiation of antiviral properties and preliminary assessment of action mechanism
    Tsypysheva Inna, Koval'skaya Alena, Petrova Polina, Lobov Alexander, Borisevich Sophia, Tsypyshev Dmitry, Fedorova* Victoria, Gorbunova Elisaveta, Galochkina* Anastasia, Zarubaev Vladimir
    Tetrahedron — 2019. — Vol. 75. — Issue. 21. — pp. 2933-2943
    DOI: 10.1016/j.tet.2019.04.021
16. DNA i-Motifs With Guanidino-i-Clamp Residues: The Counterplay Between Kinetics and Thermodynamics and Implications for the Design of pH Sensors
    Tsvetkov* Vladimir B., Zatsepin Timofei S., Turaev Anton V., Farzan Valentina M., Pozmogova Galina E., Aralov Andrey V., Varizhuk Anna M.
    Computational and Structural Biotechnology Journal — 2019. — Vol. 17. — Issue. . — pp. 527-536
    DOI: 10.1016/j.csbj.2019.04.006
17. Effect of alpha-lactalbumin and lactoferrin oleic acid complexes on chromatin structural organization
    Lebedev Dmitry V, Zabrodskaya* Yana A., Pipich Vitaly, Kuklin Alexander I, Ramsay* Edward, Sokolov Alexey, V, Elizarova Anna Yu, Shaldzhyan* Aram A., Grudinina Natalia A., Pantina Rimma A., Wu Baohu, Shtam Tatiana A., Volnitskiy Andrey V., Schmidt Alexander E., Shvetsov Alexey, V, Vasilyev Vadim B., Isaev-Ivanov Vladimir V., Egorov* Vladimir V.
    Biochemical and Biophysical Research Communications — 2019. — Vol. 520. — Issue. 1. — pp. 136-139
    DOI: 10.1016/j.bbrc.2019.09.116
18. Effect of Surfagon on Open Field and Elevated Plus Maze Behavior of Gonadectomized and Non-Gonadectomized Male Rats
    Masalova O.O., Kazakova S.B., Savateeva-Lyubimova* T.N., Sivak* K.V., Sapronov N.S., Shabanov P.D.
    Bulletin of Experimental Biology and Medicine — 2019. — Vol. 168. — Issue. 1. — pp. 52-54
    DOI: 10.1007/s10517-019-04644-4
19. Efficient soluble expression and purification of influenza A and B nucleoproteins in E. coli
    Yolshin* N.D., Shaldzhyan* A.A., Klotchenko* S.A.
    Microbiology Independent Research (MIR) journal — 2019. — Vol. 6. — Issue. 1. — pp. 43-48
    DOI: 10.18527 / 2500-2236-2019-6-1-43-48
20. Evaluation of Antiinflammatory Activity of 4'-O-Methylhonokiol Derivatives in a Neuroinflammation Model
    Sivak* K.V., Stosman* K.I., Muzhikyan* A.A., Alexandrov* A.G., Viktorov N.B., Vaulina D.D., Gomzina N.A.
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. 5. — pp. 425-429
    DOI: 10.1134/S1068162019040113
21. Exosomes as a promising tool for research and molecular diagnostics of myeloproliferative disorders
    Parfenenkova A.N., Barkhatov I.M., Kremlev A.A., Epifanovskaya O.A., Gorshkov* A.N., Vysochinskaya* V.V., Grudinin* M.P., Kornev A.A., Afanasyev B.V.
    Cellular Therapy and Transplantation — 2019. — Vol. 8. — Issue. 2. — pp. 74-81
    DOI: 10.18620/ctt-1866-8836-2019-8-2-74-81
22. Features 2016-2018 Current Human Influenza A(H3N2) Viruses Circulating in Russia
    Petrova* P.A., Konovalova* N.I., Vassilieva* A.D., Eropkina* E.M., Ivanova* A.A., Komissarov* A.B., Eropkin* M.Yu, Danilenko* D.M.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 5-6. — pp. 655-664
    DOI: 10.15789/2220-7619-2019-5-6-655-664
23. Features of Immune Response Against Influenza Infection in Animals Vaccinated with Recombinant Cross-Protective Vaccine
    Tsybalova* L.M., Stepanova* L.A., Korotkov* A.V, Shuklina* M.A., Zaitseva* M.V., Grishchenko V., I., Kotlyarov R.Yu.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 3-4. — pp. 485-494
    DOI: 10.15789/2220-7619-2019-3-4-485-494
24. Generation and Characterization of the Monoclonal Antibody Panel Specific to the NS1 Protein of the Influenza A Virus
    Krivitskaya* V.Z., Sorokin* E.V., Tsareva* T.R., Sergeeva* M.V., Kadyrova* R.A., Romanovskaya-Roman'ko* E.A., Shaldzhyan* A.A., Petrov* S.V., Petrova* E.R., Konovalova* N.I., Petrova* P.A.
    Applied Biochemistry and Microbiology — 2019. — Vol. 54. — Issue. 7. — pp. 756-765
    DOI: 10.1134/S0003683818070049
25. Hexon-Based Scaffold for Generation of Diagnostic Monoclonal Antibodies against Diverse Adenovirus Types (English abstract only)
    Timoshicheva* T.A., Zabrodskaya* Ya.A., Amosova* I.V.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 1. — pp. 47-56
    DOI: 10.15789/2220-7619-2019-1-47-56
26. How to Fight Kinetics in Complex Radical Polymerization Processes: Theoretical Case Study of Poly(divinyl ether-alt-maleic anhydride)
    Bolshchikov Boris D., Tsvetkov* Vladimir B., Alikhanova Olga L., Serbin Alexander V.
    Macromolecular Chemistry and Physics — 2019. — Vol. 220. — Issue. 23. — pp. -1900389
    DOI: 10.1002/macp.201900389
27. In Vitro Ceftaroline Resistance Selection of Methicillin-Resistant Staphylococcus aureus Involves Different Genetic Pathways
    Gostev Vladimir, Sopova Julia, Kalinogorskaya Olga, Tsvetkova Irina, Lobzin Yuri, Klotchenko* Sergey, Sidorenko Sergey
    Microbial Drug Resistance — 2019. — Vol. 25. — Issue. 10. — pp. 1401-1409
    DOI: 10.1089/mdr.2019.0130
28. Increase in Sensitivity of HEK293FT Cells to Influenza Infection by CRISPR-Cas9-Mediated Knockout of IRF7 Transcription Factor
    A. B. Komissarov, M. V. Sergeeva, E. V. Mozhaeva, N. V. Eshchenko, A. D. Vasilieva, K. A. Vasilyev, S. P. Medvedev, A. A. Malakhova, E. A. Balakhonova, S. Yu. Malanin, T. V. Grigoryeva, E. S. Zhuravlev, D. V. Semenov, V. A. Richter and G. A. Stepanov
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. . — pp. 749-757
    DOI: 10.1134/S1068162019060232
29. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network
    Puig-Barbera Joan, Mira-Iglesias Ainara, Burtseva Elena, Cowling Benjamin J., Serhat Unal, Ruiz-Palacios Guillermo Miguel, Launay Odile, Kyncl Jan, Koul Parvaiz, Siqueira Marilda M., Sominina* Anna, & on behalf of the Global Influenza Hospital Surveillance Network (…, Afanasieva* O., Pisareva* M., Stolyarov* K., …)
    BMC Infectious Diseases — 2019. — Vol. 19. — Issue. . — pp. -415
    DOI: 10.1186/s12879-019-4017-0
30. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
    Baselga-Moreno Victor, Trushakova Svetlana, McNeil Shelly, Sominina Anna*, Nunes Marta C., Draganescu Anca, Unal Serhat, Koul Parvaiz, Kyncl Jan, Zhang Tao, Kuatbayeva Ainagul, Ben-Salah Afif, Burtseva Elena, Puig-Barbera Joan, Diez-Domingo Javier, for The Global Influenza Hospital Surveillance Network (GIHSN) (..., Afanasieva* O., Afanasieva* A., Demina* S., Dondurei* E., Eropkin* M., Fadeev* A., Generalova* L., Go* A., Golovacheva* E., Gonchar* V., Komissarov* A., Konovalova* N., Kuvarzina* S., Levanyuk* T., Lobova* T., Osidak* L., Pisareva* M., Rozhkova* E., Sintsova* K., Sirotkina* Z., Smorodintseva* E., Stolyarov* K., Sukhovetskaya* V., Tamila* M., Voloshuk* L., Yanina* M., …)
    BMC Public Health — 2019. — Vol. 19. — Issue. . — pp. -487
    DOI: 10.1186/s12889-019-6713-5
31. Long-Term Maintenance of the Functional Changes Induced by Influenza A Virus and/or LPS in Human Endothelial ECV-304 Cell Sublines
    S. S. Smirnova, M. M. Pisareva, T. D. Smirnova, K. V. Sivak & K. V. Vorobiev
    Cell and Tissue Biology — 2019. — Vol. 13. — Issue. . — pp. 283-291
    DOI: 10.1134/S1990519X19040084
32. Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway
    Plotnikova* Marina A., Klotchenko* Sergey A., Kiselev Artem A., Gorshkov* Andrey N., Shurygina* Anna-Polina S., Vasilyev* Kirill A., Uciechowska-Kaczmarzyk Urszula, Samsonov Sergey A., Kovalenko Alexey L., Vasin* Andrey V.
    Scientific Reports — 2019. — Vol. 9. — Issue. . — pp. -18240
    DOI: 10.1038/s41598-019-54208-9
33. Microneutralization Reaction Compared to Hemagglutination Inhibition Assay to Evaluate Immunogenicity of Influenza Vaccines and Influenza Diagnostics
    Krivitskaya* V.Z., Kuznecova* E.V., Majorova* V.G., Kadyrova* R.A., Lvov N.I, Go* A.A., Sominina* A.A.
    Russian Journal of Infection and Immunity — 2019. — Vol. 9. — Issue. 5-6. — pp. 763-772
    DOI: 10.15789/2220-7619-2019-5-6-763-772
34. Morphological study of telocytes in the left atrium in patients with long-term persistent atrial fibrillation (English abstract only)
    Mitrofanova L.B., Khazratov A.O., Gurshchenkov A.V., Osadchii A.M., Gorshkov* A.N., Galkovsky B.E.
    Russian Journal of Cardiology — 2019. — Vol. 24. — Issue. 7. — pp. 53-62
    DOI: 10.15829/1560-4071-2019-7-53-62
35. New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties
    Volodina Yulia L., Dezhenkova Lyubov G., Tikhomirov Alexander S., Tatarskiy Victor V., Kaluzhny Dmitry N., Moisenovich Anastasia M., Moisenovich Mikhail M., Isagulieva Alexandra K., Shtil Alexander A., Tsvetkov* Vladimir B., Shchekotikhin Andrey E.
    European Journal of Medicinal Chemistry — 2019. — Vol. 165. — Issue. . — pp. 31-45
    DOI: 10.1016/j.ejmech.2018.12.068
36. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes
    Mariotti Francesca, Magi, Gian Enrico, Gavazza Alessandra, Vincenzetti, Silvia, Komissarov* Andrey, Shneider Alex, Venanzi Franco Maria
    Veterinary and Comparative Oncology — 2019. — Vol. 17. — Issue. 4. — pp. 570-577
    DOI: 10.1111/vco.12523
37. Pathology of A(H5N8) (Clade 2.3.4.4) Virus in Experimentally Infected Chickens and Mice
    E.A. Prokopyeva, V.A. Zinserling, Y.-C. Bae, Y. Kwon, O.G. Kurskaya, I.A. Sobolev, P.M. Kozhin, A. Komissarov*, A.Fadeev*, V.Petrov, A.M. Shestopalov, K.A. Sharshov
    Interdisciplinary Perspectives on Infectious Diseases — 2019. — Vol. . — Issue. Article ID 4124865. — pp. -
    DOI: 10.1155/2019/4124865
38. Peculiarities of free-radical processes and neurupsychological status in patients with chronic generalized periodontitis and possibility of correcting their impairments with antioxidant therapy
    Saulin M.P., Bolevich S., Savateeva-Liubimova* T., Sivak* K., Silina E.
    Serbian Journal of Experimental and Clinical Research — 2019. — Vol. 20. — Issue. 2. — pp. 55-64
    DOI: 10.2478/sjecr-2019-0034
39. Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
    Shtam Tatiana, Naryzhny Stanislav, Samsonov Roman, Karasik David, Mizgirev Igor, Kopylov Artur, Petrenko Elena, Zabrodskaya* Yana, Kamyshinsky Roman, Nikitin Daniil, Sorokin Maxim, Buzdin Anton, Gil-Henn Hava, Malek Anastasia
    Breast Cancer Research and Treatment — 2019. — Vol. 174. — Issue. 1. — pp. 129-141
    DOI: 10.1007/s10549-018-5043-0
40. Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site
    Kolganova Natalia A., Tsvetkov* Vladimir B., Smirnov Igor P., Timofeev Edward N.
    Nucleic Acid Therapeutics — 2019. — Vol. 29. — Issue. 4. — pp. 208-217
    DOI: 10.1089/nat.2018.0757
41. Probing the Nitroindole-Modified Central Loop of Thrombin Aptamer HD1 as a Recognition Site
    Natalia A. Kolganova, Vladimir B. Tsvetkov*, Igor P. Smirnov, and Edward N. Timofeev
    Nucleic Acid Therapeutics — 2019. — Vol. 29. — Issue. 4. — pp. -
    DOI: 10.1089/nat.2018.0757
42. Regulation of Aggregation of Self-Associated Peptides, Including N-Terminal Fragments of the Alzheimer's beta-Amyloid Peptide, by Nitro Derivatives of Azoloazine (vol 44, pg 665, 2018)
    Mirgorodskaya* O.A., Kozmin Y.P., Protasov* A.V., Toropygin I.Y., Oleinikov V.A.
    Russian Journal of Bioorganic Chemistry — 2019. — Vol. 45. — Issue. 5. — pp. 430-430
    DOI: 10.1134/S1068162019010096
43. Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers
    Timin A.S., Peltek O.O., Zyuzin M.V., Muslimov* A.R., Karpov T.E., Epifanovskaya O.S., Shakirova A.I., Zhukov M.V., Tarakanchikova Y.V., Lepik K.V., Sergeev V.S., Sukhorukov G.B., Afanasyev B.V.
    ACS Applied Materials and Interfaces — 2019. — Vol. 11. — Issue. 14. — pp. 13091-13104
    DOI: 10.1021/acsami.8b22685
44. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1
    Nicolodi Christina, Groiss Franz, Kiselev* Oleg, Wolschek Markus, Seipelt Joachim, Muster Thomas
    Vaccine — 2019. — Vol. 37. — Issue. 28. — pp. 3722-3729
    DOI: 10.1016/j.vaccine.2019.05.013
45. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
    Isakova-Sivak Irina, Matyushenko Victoria, Kotomina Tatiana, Kiseleva Irina, Krutikova Elena, Donina Svetlana, Rekstin Andrey, Larionova, Natalia, Mezhenskaya Daria, Sivak* Konstantin, Muzhikyan* Arman, Katelnikova Anastasia, Rudenko Larisa
    Vaccines — 2019. — Vol. 7. — Issue. 3. — pp. -61
    DOI: 10.3390/vaccines7030061
46. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
    Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov* D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G.
    The Lancet HIV — 2019. — Vol. 6. — Issue. 4. — pp. -
    DOI: 10.1016/S2352-3018(18)30362-X
47. Spontaneous Proteolytic Processing of Human Recombinant Anti-Mullerian Hormone: Structural and Functional Differences of the Molecular Forms
    Rak A.Ya., Trofimov A.V., Protasov E.A., Rodin S.V., Zhahov A.V., Zabrodskaya* Ya.A., Ischenko A.M.
    Applied Biochemistry and Microbiology — 2019. — Vol. 55. — Issue. 1. — pp. 13-20
    DOI: 10.1134/S0003683819010149
48. Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives
    Khaziev Rail, Shtyrlin Nikita, Pavelyev Roman, Nigmatullin Raushan, Gabbasova Raylya, Grishaev Denis, Shtro Anna, Galochkina* Anastasia, Nikolaeva Yulia, Vinogradova Tatiana, Manicheva Olga, Dogonadze Marine, Gnezdilov Oleg, Sokolovich Evgenii, Yablonskiy Petr, Balakin Konstantin, Shtyrlin Yurii
    Letters In Drug Design & Discovery — 2019. — Vol. 16. — Issue. 12. — pp. 1360-1369
    DOI: 10.2174/1570180816666190911150705
49. Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents
    Yarovaya Olga, I, Sokolova Anastasiya S., Mainagashev Iliya Ya, Volobueva Alexandrina S., Lantseva Khristina, Borisevich Sophia S., Shtro* Anna A., Zarubaev Vladimir V., Salakhutdinov Nariman F.
    Bioorganic & Medicinal Chemistry Letters — 2019. — Vol. 29. — Issue. 23. — pp. -126745
    DOI: 10.1016/j.bmcl.2019.126745
50. Synthesis of C5-C6 Derivatives of 1,3-Dimethyl-5-Fluorouracil and 5-Fluorouracil. Screening for Antiviral Activity
    Chernikova I.B., Khursan S.L., Eropkin* M.Yu., Yunusov M.S.
    Pharmaceutical Chemistry Journal — 2019. — Vol. 53. — Issue. 2. — pp. 108-112
    DOI: 10.1007/s11094-019-01962-9
51. Synthesis of New 4,4a-Dihydroxanthones via [4+2]-Cycloaddition Reaction
    Chernov N.M., Moroz T.V., Shutov R.V., Kuz'mich* N.N., Shchegolev A.E., Sopova M.V., Yakovlev I.P.
    Russian Journal of General Chemistry — 2019. — Vol. 89. — Issue. 12. — pp. 2463-2470
    DOI: 10.1134/S1070363219120223
52. The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections
    Klausberger Miriam, Leneva Irina A., Falynskova Irina N., Vasiliev* Kirill, Poddubikov Alexander V., Lindner Claudia, Kartaschova Nadezhda P., Svitich Oxana A., Stukova* Marina, Grabherr, Reingard, Egorov* Andrej
    Vaccines — 2019. — Vol. 7. — Issue. 4. — pp. -187
    DOI: 10.3390/vaccines7040187
53. Use of hexon as an antigen for the production of monoclonal antibodies capable of detecting multiple adenovirus types
    Timoshicheva* Tatyana A., Zabrodskaya* Yana A., Ramsay* Edward, Amosova* Irina V.
    Biologicals — 2019. — Vol. 58. — Issue. . — pp. 44-49
    DOI: 10.1016/j.biologicals.2019.01.006
54. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia
    Barocas Joshua A., So-Armah Kaku, Cheng Debbie M., Lioznov* Dmitry, Baum Marianna, Gallagher Kerrin, Fuster Daniel, Gnatienko Natalia, Krupitsky Evgeny, Freiberg Matthew S., Samet Jeffrey H.
    Plos One — 2019. — Vol. 14. — Issue. 6. — pp. -
    DOI: 10.1371/journal.pone.0218852

2018

1. Effect of Shock Waves Generated by Pulsed Electric Discharges in Water on Yeast Cells and Virus Particles

   Girdyuk, A. E.; Gorshkov, A. N.; Egorov, V. V.; Kolikov, V. A.; Snetov, V. N.; Shneerson, G. A.

   Technical Physics. – 2018. – Volume 63, Issue 2, pp. 285–290 

   DOI: 10.1134/S1063784218020159
2. Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia
   Gnatienko, N.; Freiberg, M. S.; Blokhina, E.; Yaroslavtseva, T.; Bridden, C.;  Cheng, D. M.; Chaisson, C. E.; Lioznov, D.; Bendiks, S.; Koerbel, G.; Coleman, S. M.; Krupitsky, Ev.; Samet, J. H.
   HIV Clinical Trials.– 2018. – Volume 19, Issue 3, pp. 101-111
   DOI: 10.1080/15284336.2018.1459344
3. Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses
   Ilyina, I. V; Zarubaev, V. V.; Lavrentieva, I. N.; Shtro, A. A.; Esaulkova, Ia. L.; Korchagina, D. V.; Borisevich, S. S.; Volcho, K. P.; Salakhutdinov, N. F.
   Bioorganic & Medicinal Chemistry Letters. - 2018.-  Volume 28, Issue 11, pp. 2061-2067
   DOI: 10.1016/j.bmcl.2018.04.057
4. beta-D-Ribofuranosyl substituted polyfluoroalkylpyrazoles and their activity against the influenza virus
   Ivanova, A. E.; Burgart, Ya. V.; Saloutin, V. I.; Orshanskaya, Ya. R.; Zarubaev, V. V.
   Mendeleev Communications.- 2018. - Volume 28, Issue 1, pp. 52-54
   DOI: 10.1016/j.mencom.2018.01.017
5. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18 (vol 35, pg 4828, 2017)
   Melidou, A.; Broberg, E.; Adlhoch, C.; Snacken, R.; Penttinen, P.; Pereyaslov, D., Brown, C,;… European Region Influenza Surveill
   Vaccine. - 2018. - Volume 36, Issue 19, pp. 2740-2741
   DOI: 10.1016/j.vaccine.2017.12.039
6. Telocytes in the human sinoatrial node
   Mitrofanova, L. B.; Gorshkov, A. N.; Konovalov, P. V.; Krylova, J. S.
   Journal of Cellular and Molecular Medicine. - 2018. - Volume 22, Issue 1, pp. 521-532
   DOI: 10.1111/jcmm.13340
7. Synthesis and Biological Activity of 16,33-O,O-Diformyl-16,17-dihydro-16(S),17(R)-dihydroxyoligomycin A and 33-O-Formyloligomycin A
   Omelchuk, O. A.; Belov, N. M.; Tsvetkov, V. B.; Korolev, A. M.; Dezhenkova, L. G.; Grammatikova,N. E.; Lysenkova, L. N.; Bekker, O. B.; Danilenko, V. N.; Shchekotikhin, A. E.
   Macroheterocycles. - 2018. - Volume 11, Issue 2, pp. 181-192
   DOI: 10.6060/mhc170834o
8. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults
   Sarsenbayeva, G. Volgin, Ye; Kassenov, M.; Issagulov, Tr.; Bogdanov, N.; Sansyzbay, A.; Stukova, M.; Buzitskaya, Zh.; Kulmagambetov, I.; Davlyatshin, T.; Khairullin, B.
   Human Vaccines & Immunotherapeutics.- 2018. - Volume 14, Issue 3, SI, pp. 609-614
   DOI: 10.1080/21645515.2017.1387345
9. Y Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial
   Sarsenbayeva, G.; Volgin, Ye.; Kassenov, M.; Issagulov, T.; Bogdanov, N.; Sansyzbay, A.; Abitay, R.; Nurpeisova, A.; Sagymbay, A.; Koshemetov, Z.; Stukova, M.; Buzitskaya, Zh.; ëulmagambetov, I.; Karabayeva, D.; Davlyatshin, T.; Khairullin, B.
   Journal of Medical Virology. - 2018. - Volume 90, Issue 1, pp. 41-49
   DOI: 10.1002/jmv.24922
10. Influence of the linking order of fragments of HA2 and M2e of the influenza A virus to flagellin on the properties of recombinant proteins
    Stepanova, L. A., Kotlyarov, R. Y., Shuklina, M. A., (...), Ravin, N. V., Tsybalova, L. M.
    Acta Naturae. - 2018. - Volume 10, Issue 1, pp. 85-94
    DOI
11. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes
    Stepanova, L. A.; Mardanova, Eu. S.; Shuklina, M. A.; Blokhina, E. A.; Kotlyarov, R. Y.; Potapchuk, M. V.; Kovaleva, A. A.; Vidyaeva, I. G.; Korotkov, A.r V.; Eletskaya, E. I.; Ravin, N.i V.; Tsybalova, L. M.
    Journal of Biomedical Science. - 2018. - Volume 25 : 33
    DOI: 10.1186/s12929-018-0433-5
12. i-Clamp phenoxazine for the fine tuning of DNA i-motif stability
    Tsvetkov, V.  B.; Zatsepin, T. S.; Belyaev, E. S.; Kostyukevich, Y. I.; Shpakovski, G. V.; Podgorsky, V. V.; Pozmogova, G. E.; Varizhuk, A. M.; Aralov, A. V.
    Nucleic Acids Research.- 2018. - Volume 46, Issue 6, pp. 2751-2764
    DOI: 10.1093/nar/gky121
13. Synthesis of Silver Glyconanoparticles Based on 3-Thiopropionylhydrazones of Mono- and Disaccharides 
    Vasileva, M. Yu.; Ershov, A. Yu.; Baigildin, V. A.; Lagoda, I. V.; Kuleshova, L. Yu.; Shtro, A. A.; Zarubaev, V. V.; Yakimanskii, A. V.
    Russian Journal of General Chemistry. - 2018. - Volume 88, Issue 1, pp. 109-113
    DOI: 10.1134/S1070363218010176
14. First example of the cascade acylation/IMDAViene reaction sequence, leading to N-arylbenzo[f]isoindole-4-carboxylic acids possessing anti-viral activity
    Voronov, A. A.; Alekseeva, K. A.; Ryzhkova, E. A.; Zarubaev, V. V.; Galochkina, A. V.; Zaytsev, V. P.; Majik, Mahesh S.; Tilve, Santosh G.; Gurbanov, Atash V.; Zubkov, F. I.
    Tetrahedron Letters.- 2018. - Volume 59, Issue 12, pp. 108-1111
    DOI: 10.1016/j.tetlet.2018.02.015
15. The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity
    Zabrodskay, Ya. A.; Lebedev, D. V.; Egorova, M. A.; Shaldzhyan, A. A.; Shvetsov, A. V.; Kuklin, A. I.; Vinogradova, D. S.; Klopov, N. V.; Matusevich, O. V.; Cheremnykh, T. A.; Dattani, R.; Egorov, V. V.
    Biophysical Chemistry. - 2018. - Volume 234, pp. 16-23
    DOI: 10.1016/j.bpc.2018.01.001
16. Changing Times: Fluorescence-Lifetime Analysis of Amyloidogenic SF-IAPP Fusion  Protein
    Antimonova, O. I Lebedev, D. V Zabrodskaya, Ya. A Grudinina, N. A Timkovsky, A. L Ramsay, E. Shavlovsky, M. M Egorov V. V.
    Journal of Structural Biology. - 2018
    DOI: 10.1016/j.jsb.2018.11.006
17. Conserved RNA secondary structure of the NS segment as a possible additional influenza viral pathogenicity factor
    Baranovskaya, I.; Sergeeva, M.; Brodskaia, A.; Taraskin, A.; Vasin, A.
    FEBS OPEN BIO. - 2018. - Volume: 8. ðÒÉÌÏÖÅÎÉÅ: 1. - P. 204
    DOI
18. Expression in Plants of a Recombinant Protein Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin of Influenza Virus
    Blokhina, E. A.; Mardanova, E. S.; Tsybalova, L. M.; Ravin, N. V.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY. - 2018. - Volume 54, Issue 4. - P. 404-409
    DOI
19. Practical procedure for a theoretical investigation of thermodynamics and kinetics aspects of different-scale radical reactions from addition and cyclization to cyclocopolymerization involving maleic anhydride and divinyl ether
    Bolshchikov, B. D.; Tsvetkov, V. B.; Serbin, A. V.
    POLYMER. - 2018. - Volume 146. - P. 429-445
    DOI: doi.org/10.1016/j.polymer.2018.05.032
20. Female Gender and HIV Transmission Risk Behaviors Among People Living with HIV Who Have Ever Used Injection Drugs in St. Petersburg, Russia
    Wagman, Jennifer A.; Samet, Jeffrey H.; Cheng, Debbie M.; Gnatienko, Natalia; Raj, Anita; Blokhina, Elena; Toussova, Olga; Forman, Leah S.; Lioznov, Dmitry; Tsui, Judith I.
    AIDS AND BEHAVIOR. - 2018. - Volume 22. - Issue 9. - P.2830-2839
    DOI: 10.1007/s10461-018-2149-7
21. Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity
    Zarubaev, V. V.; Pushkina, E. A.; Borisevich, S. S.; Galochkina, A. V.; Garshinina, A. V.; Shtro, Anna A.; Egorova, Anna A.; Sokolova, A. S.; Khursan, Sergey L.; Yarovaya, Olga I.; Salakhutdinov, N. F.
    VIROLOGY. - 2018. - Volume 524. - P. 69-77
    DOI: 10.1016/j.virol.2018.08.011
22. A double-edged sword: supramolecular complexes of triazavirine display multicenter binding effects which influence aggregate formation

    Zabrodskaya, Ya.A., Shvetsov,A.V., Tsvetkov, V.B. Egorov, V. V.

    Journal of Biomolecular Structure and Dynamics. - 2018. - Aug 3. - P. 1-19 

    DOI: 10.1080/07391102.2018.1507837
23. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
    Tsybalova, L. M.; Stepanova, L. A.; Shuklina, M. A.; Mardanova, E. S.; Kotlyarov, R. Y.; Potapchuk, M., V; Petrov, Sergei A.; Blokhina, Elena A.; Ravin, Nikolai, V
    PLOS ONE. - 2018. - Volume 13. - Issue 8,  Article № e0201429
    DOI: 10.1371/journal.pone.0201429
24. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriersI
    Brodskaia, A. V; Timin, A S.; Gorshkov, A N.; Ó ÓÏÁ×ÔÏÒÁÍÉ
    Antiviral Research. - 2018. - Volume 158. - P. 147-160 
    DOI: 10.1016/j.antiviral.2018.08.003
25. Comparative study of diethylaminoethyl-chitosan and methylglycol-chitosan as potential non-viral vectors for gene therapy
    Raik S.V., Petrova V.A., Kritchenkov A.S., Skorik Y.A., Andranovitš S., Casettari L., Xu Y., Lam J.K.- W., Morris G.A., Brodskaia A.V.
    Polymers. - 2018. - Volume 10. - Issue 4. - P. 442
    DOI: 10.3390/polym10040442
26. Functional Properties of Circulating Exosomes Mediated by Surface-Attached Plasma Proteins
    Shtam ô., Naryzhny S., Kopylov A., Petrenko E., Samsonov R., Kamyshinsky R. , Zabrodskaya Ya., Nikitin D., Sorokin M., Buzdin A., Malek A.
    J Hematol. - 2018. - Volume 7. - Issue 4. - P. 149-153 
    DOI: 10.14740/jh412w
27. The European Virus Archive goes global: A growing resource for research
    Romette, J. L.; Prat, C. M.; Gould, E. A…, Eropkin, M.Y.
    Antiviral Research. - 2018. - Volume 158. - P. 127-134
    DOI: 10.1016/j.antiviral.2018.07.017
28. Novel 18-crown-6-ether containing mono- and bisstyryl dyes derived from pyridine moiety as fluorescent dyes for non-covalent interaction with DNA
    Lebedeva, A. Y.; Fedorova, O.A.; Tsvetkov, V. B.;  Grinberg, V. Y.; Grinberg, N. V.;  Burova, T.V.; Dubovik, A.S.; Babievsky, K.K.; Fedorov, Y. V.
    Antiviral Research. - 2018. - Volume 158. - P. 147-160 
    DOI: 10.1016/j.dyepig.2018.04.038
29. Cross-protective efficacy of monovalent live influenza B vaccines against genetically different lineages of B/Victoria and B/Yamagata in ferrets
    Kiseleva I., Krutikova E., Stepanova E., Donina S., Pisareva M.,  Krivitskaya V., Rekstin A., Grace Sparrow E., Torelli G., Rudenko L.
    DYES AND PIGMENTS. - 2018. - Volume 157. - P. 80-92
    DOI: 10.1155/2018/9695628
30. False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts
    Coleman S.M., Lloyd-Travaglini C.A., Winter M.R., Gnatienko N., Bridden C., Samet J.H., Blokhina E., Lioznov D., Adong J.,  Liegler T., Hahn J.A.
    HIV Clinical Trials. - 2018. - Volume 19. - Issue 1. - P. 15-22
    DOI: 10.1080/15284336.2018.1429846
31. The influence of hydrodynamic conditions and chamber geometry on the analytical signal from integrated biochips
    Esikova, N.A., Bulyanitsa, A.L., Klotchenko, S.A., Taraskin, A.S., Evstrapov, A.A.
    Journal of Physics: Conference Series. - 2018. - 1135(1). - 012021
    DOI: 10.1088/1742-6596/1135/1/012021
32. Antiviral activity of Embelia ribes Burm. f. against influenza virus in vitro
    Hossan, Md Sh.; Fatima, A.; Rahmatullah, M.; Khoo, T. J.; Nissapatorn, V.; Galochkina, A. V.; Slita, A. V.; Shtro, A. A.; Nikolaeva, Yu.; Zarubaev, V. V.; Wiart, Ch.
    ARCHIVES OF VIROLOGY. - 2018. - Volume 163. - Issue 8. - P. 2121-2131
    DOI: 10.1007/s00705-018-3842-6
33. Psychological features of abstinent heroin users before and after rehabilitation in Saint Petersburg, Russia

    Galankin T., Lioznov D., Nikolaenko S., McNutt L.A., Leckman-Westin E., Smith P.F.

    BMC Research Notes. - 2018. - Volume 11. - Issue 1. - P. 589

    DOI: 10.1186/s13104-018-3699-5
34. Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia

    Gnatienko N, Wagman JA, Cheng DM, Bazzi AR, Raj A, Blokhina E, Toussova O, Forman LS, Lioznov D, Bridden C, Sullivan M, Bryant K, Samet JH, Tsui JI.

    PLoS One. 2018 Nov 16;13(11):e0207402 

    DOI: 10.1371/journal.pone.0207402

2017

* denotes publications with non–RII co–authors.

Research papers:

1. Features of the terahertz spectra of iron oxide nanoparticles in a silicon dioxide shell and of iron oxide and hydroxide nanoparticles
   Afonin V., Balbekin N.S., Gareev G.Z., Gareev K.G., Gorshkov A.N., Korolev D.V., Luchinin V.V., Smolyanskaya O.A.
   Journal of Optical Technology. – 2017. – Vol. 84, Issue 8, pp. 515-520
   DOI / PubMed Abstract
2. Synthetic Route to 4,4a- and 3,4-Dihydroxanthones through [4+2] Cycloaddition and Base-Assisted Sigmatropic Rearrangement
   Chernov N, Shutov R, Sharoyko V, Kuzmich N, Belyakov A, Yakovlev I. *
   European Journal of Organic Chemistry. – 2017. – Volume 2017, Issue 19, May 18, Pages 2836–2841
   DOI / PubMed Abstract
3. Structural features of the ionic self-complementary amyloidogenic peptide
   Egorov V V, Zabrodskaya Ya A, Lebedev D V, Gorshkov A N and Kuklin A I *
   IOP Conf. Series: Journal of Physics. – 2017. – Conf. Series 848 012022
   DOI / PubMed Abstract
4. Synthesis and antiviral activity of novel glycyrrhizic acid conjugates with D-amino acid esters
   Fayrushina A.I., Baltina Jr. L.A., Baltina L.A., Konovalova N.I., Petrova P.A., Eropkin M.Yu. *
   Russian Journal of Bioorganic Chemistry. – 2017. – Volume 43, Issue 4, pp 456–462
   DOI / PubMed Abstract
5. Modern approaches for identification of modified nucleotides in RNA
   Filippova J.A., Semenov D.V., Juravlev E.S., Komissarov A.B., Richter V.A., Stepanov G.A.
   Biochemistry. – 2017. – Volume 82, Issue 11, pp 1217–1233
   DOI / PubMed Abstract
6. A comparison study between electrospun polycaprolactone and piezoelectric poly(3-hydroxybutyrate-co-3-hydroxyvalerate) scaffolds for bone tissue engineering
   Gorodzha S.N., Muslimov A.R., Syromotina D.S., Timin A.S., Tcvetkov N.Y., Lepik K.V., Petrova A.V., Surmeneva M.A., Gorin D.A., Sukhorukov G.B., Surmenev R.A. *
   Colloids and Surfaces B: Biointerfaces. – 2017. – Volume 160, 1 December 2017, Pages 48-59
   DOI / PubMed Abstract
7. P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
   Halenova T., Savchuk O., Ostapchenko L., Chursov A., Fridlyand N., Komissarov A.B., Venanzi F., Kolesnikov S.I.,  Sufianov A.A., Sherman M.Y., Gabai V.L. and Shneider A.M. *
   Oncotarget. – 2017. – 8:56030-56040
   DOI / PubMed abstract
8. Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo
   Hock K., Laengle J., Kuznetsova I., Egorov A., Hegedus B., Dome B., Wekerle T., Sachet M., Bergmann M. *
   Surgery. – 2017. – Volume 161, Issue 3, Pages 735–746
   DOI / PubMed abstract
9. Development of a realtime RT-PCR assay for the rapid detection of influenza A(H2) viruses
   Komissarov A., Fadeev A., Kosheleva A., Grudinin M.
   Molecular and Cellular Probes. – 2017. – Volume 35, October 2017, Pages 57-63
   DOI / PubMed abstract
10. Synthesis of Conjugates of Lupane-Type Pentacyclic Triterpenoids with 2-Aminoethane- and N-Methyl-2-Aminoethanesulfonic Acids. Assessment of in vitro Toxicity
    Komissarova N.G., Dubovitskii S.N., Shitikova O.V., Vyrypaev E.M., Spirikhin L.V., Eropkina E.M., Lobova T.G., Eropkin M.Yu., Yunusov M.S. *
    Chemistry of Natural Compounds. – 2017. – September 2017, Volume 53, Issue 5,  pp 907–914
    DOI / PubMed Abstract
11. Synthesis of new heterocyclic dehydroabietylamine derivatives and their biological activity
    Kovaleva K.S., Yarovaya O.I., Shernyukov A.V., Zarubaev V.V., Shtro A.A., Orshanskaya Y.R., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 3, pp 364–370
    DOI / PubMed abstract
12. Alzheimer’s disease: as it was in the beginning
    Kozlov S., Afonin A., Evsyukov I., Bondarenko A. *
    Reviews in the Neurosciences. – 2017. – 07-12
    DOI / PubMed Abstract
13. TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
    Kuzmich N.N., Sivak K.V., Chubarev V.N., Porozov Y.B., Savateeva-Lyubimova T.N., Peri F. *
    Vaccines. – 2017. – 5(4), 34
    DOI / PubMed Abstract
14. Targeting an oncolytic influenza A virus to tumor tissue by elastase
    Kuznetsova I., Arnold T., Aschacher T., Schwager C., Hegedus B., Garay T., Stukova M., Pisareva M., Pleschka S., Bergmann M., Egorov A. *
    Molecular Therapy - Oncolytics. – 2017. – Volume 7, 15 December 2017, Pages 37-44
    DOI / PubMed Abstract
15. Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A
    Lysenkova L.N., Saveljev O.Y., Grammatikova N.E., Tsvetkov V.B., Bekker O.B., Danilenko V.N., Dezhenkova L.G., Bykov E.E., Omelchuk O.A., Korolev A.M., Shchekotikhin A.E. *
    The Journal of Antibiotics. – 2017. – April 19
    DOI / PubMed abstract
16. Reintroduction of highly pathogenic avian influenza A/H5N8 virus of clade 2.3.4.4. in Russia
    Marchenko V.Y., Susloparov I.M., Komissarov A.B., Fadeev A., Goncharova N.I., Shipovalov A.V., Svyatchenko S.V., Durymanov A.G., Ilyicheva T.N., Salchak L.K., Svintitskaya E.P., Mikheev V.N., Ryzhikov A.B. *
    Archives of Virology. – 2017. – pp 1–5
    DOI / PubMed abstract
17. Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X
    Mardanova E.S., Blokhina E.A., Tsybalova L.M., Peyret H., Lomonossoff G.P. and Ravin N.V. *
    Front. Plant Sci. – 2017. – 8:247
    DOI / PubMed Abstract
18. Mesenchymal Stem Cells Engineering: Microcapsules-Assisted Gene Transfection and Magnetic Cell Separation
    Muslimov A.R., Timin A.S., Petrova A.V., Epifanovskaya O.S., Shakirova A.I., Lepik K.V., Gorshkov A., Il’inskaja E.V., Vasin A.V., Afanasyev B.V., Fehse B., Sukhorukov G.B. *
    ACS Biomaterials Science. – 2017. – 3 (10), pp 2314–2324
    DOI / PubMed Abstract
19. Influenza Antiviral Activity of Br-Containing [2R,4R(S),4aR,7R,8aR]-4,7-Dimethyl-2-(Thiophen-2-YL)Octahydro-2H-Chromen-4-Ols Prepared from (–)-Isopulegol
    Nazimova E.V., Shtro A.A., Anikin V.B., Patrusheva O.S., Il′ina I.V., Korchagina D.V., Zarubaev V.V., Volcho K.P., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 2, pp 260–264
    DOI / PubMed abstract
20. Ceruloplasmin gene expression profile changes in the rat mammary gland during pregnancy, lactation and involution
    Platonova N.A., Orlov I.A., Klotchenko S.A., Babich V.S., Ilyechova E.Y., Babich P.S., Garmai Y.P., Vasin A.V., Tsymbalenko N.V., Puchkova L.V. *
    Journal of Trace Elements in Medicine and Biology. – 2017. – Volume 43, September 2017, Pages 126-134
    DOI / PubMed abstract
21. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors
    Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM *
    Oncotarget. – 2017. – 8:53730-53739
    DOI / PubMed abstract
22. Impact of mutations in nucleoprotein on replication of influenza virus A/Hong Kong/1/68/162/35 reassortants at different temperatures
    Pulkina A.A., Sergeeva M.V., Petrov S.V., Fadeev A.V., Komissarov A.B., Romanovskaya-Romanko E.A., Potapchuk M.V., Tsybalova L.M.
    Molecular Biology. – 2017. – Volume 51, Issue 2, pp 333–338
    DOI / PubMed abstract
23. A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research
    Sarsenbayeva G, Volgin Y, Kassenov M, Issagulov T, Bogdanov N, Nurpeisova A, Sagymbay A, Abitay R, Stukova M, Sansyzbay A, Khairullin B
    Journal of Medical Virology. – 2017. – Jul;89(7):1168-1173
    DOI / PubMed Abstract  
24. The Oxime Derivatives of 1-R-1H-Naphtho[2.3-d][1.2.3]triazole-4.9-dione 2-oxides: Synthesis and Properties
    Shtil AA, Gornostaev LM, Tsvetkov VB, Markova AA, Lavrikova TI, Khalyavina YG, Kuznetsova AS, Kaluzhny DN, Shunayev AV, Tsvetkova MV, Glazunova VA, Chernyshev VV *
    Anticancer Agents Med Chem. – 2017. – Vol 17
    DOI / PubMed abstract
25. Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure
    Shvetsov A., Zabrodskaya Y., Nekrasov P., Egorov V. *
    Journal of Biomolecular Structure and Dynamics. – 2017. – Published online: 12 Sep 2017, pp 1-5
    DOI / PubMed Abstract
26. Regio- and diastereoselectivity of the cycloaddition of aldonitrones with benzylidenecyclopropane: An experimental and theoretical study
    Sirotkina EV, Efremova MM, Novikov AS, Zarubaev VV, Orshanskaya IR, Starova GL, Kostikov RR, Molchanov AP *
    Tetrahedron. – 2017. – Volume 73, Issue 21, Pages 3025–3030
    DOI / PubMed abstract
27. Effect of influenza A virus and bacterial lipopolysaccharide on proliferation and expression of cytokines and other cellular factors in the endothelial cell line ECV-304
    Smirnova S.S., Pisareva M.M., Smirnova T.D., Plotnikova M.A., Sivak K.V., Vorobiev K.V. *
    Cell and Tissue Biology. – 2017. – Volume 11, Issue 2, pp 147–154
    DOI / PubMed abstract
28. Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus
    Sokolova  A. S., Yarovaya O. I., Semenova M.D., Shtro A. A., Orshanskaya I.R., Zarubaev V. V.  and  Salakhutdinov N.F. *
    MedChemComm. – 2017. – 8(5), Pages 960—963
    DOI / PubMed Abstract
29. Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
    Sokolova A.S., Yarovaya O.I, Baev D.S., Shernyukov A.V., Shtro A.A., Zarubaev V.V., Salakhutdinov N.F. *
    European Journal of Medicinal Chemistry. – 2017. – Volume 127, Pages 661–670
    DOI / PubMed abstract
30. Synthesis and biological activity of heterocyclic borneol derivatives
    Sokolova A.S., Yarovaya O.I., Shtro A.A., Borisova M.S., Morozova E.A., Tolstikova T.G., Zarubaev V.V., Salakhutdinov N.F. *
    Chemistry of Natural Compounds. – 2017. – Volume 53, Issue 3, pp 371–377
    DOI / PubMed abstract
31. Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection
    Timin A.S., Muslimov A.R., Petrova A.V., Lepik K.V., Okilova M.V., Vasin A.V., Afanasyev B.V., Sukhorukov G.B. *
    Scientific Reports. – 2017. – 7, Article number: 102
    DOI / PubMed abstract
32. In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles
    Toropova Y.G., Golovkin A.S., Malashicheva A.B., Korolev D.V., Gorshkov A.N., Gareev K.G., Afonin M.V., Galagudza M.M. *
    International Journal of Nanomedicine. – 2017. – Volume 12, Pages 593—603
    DOI / PubMed abstract
33. The expanding repertoire of G4 DNA structures
    Varizhuk A., Ischenko D., Tsvetkov V., Novikov R., Kulemin N., Kaluzhny D., Vlasenok M., Naumov V., Smirnov I, Pozmogova G. *
    Biochimie. – 2017. – Volume 135, April 2017, Pages 54–62
    DOI / PubMed abstract
34. Interaction of Bacteroides fragilis toxin with outer membrane vesicles reveals new mechanism of its secretion and delivery
    Zakharzhevskaya N.B., Tsvetkov V.B., Vanyushkina A.A., Varizhuk A.M., Rakitina D.V., Podgorsky V.V., Vishnyakov I.E., Kharlampieva D.D., Manuvera V.A., Lisitsyn F.V., Gushina E.A., Lazarev V.N., Govorun V.M. *
    Frontiers in Cellular and Infection Microbiology. – 2017. – 
    DOI / PubMed abstract
35. In Vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus
    Argentova V.V., Aliev T.K, Zarubaev V.V., Klotchenko S.A., Shtro A.A., Sergeeva M.V., Toporova V,A., Dolgikha D.A.,  Sveshnikov P.G., Vasin A.V. and Kirpichnikov M.P. *
    Molecular Biology.- 2017.-V. 51, № 6; ò. 804–812 
    DOI / PubMed abstract
36. Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity
    Artyushin, O.I.; Sharova, E. V.; Vinogradova, N. M.; Genkina, G. K.; Moiseeva, A. A.; Klemenkova, Z. S.; Orshanskaya, Ia. R.; Shtro, A. A.; Kadyrova, R. A.; Zarubaev, V. V.; Yarovaya, O. I.; Salakhutdinov, N. F.; Brel, V. K.
    Bioorganic & Medicinal Chemistry Letters.- 2017.- Volume 27, Issue 10,  pp 2181-2184
    DOI / PubMed abstract
37. Synthesis and Antiviral Activity of Glycyrrhizic-Acid Conjugates with Aromatic Amino Acids
    Baltina, L. A., Jr.; Fairushina, A. I.; Baltina, L. A.; Eropkin, M. Yu.; Konovalova, N. I.; Petrova, P. A.; Eropkina, E. M.
    Chemistry of Natural Compounds. - 2017. - Volume 53, Issue 6, pp 1096-1100
    DOI / PubMed abstract
38. Anti-influenza activity of monoterpene-containing substituted coumarins
    Khomenko, T. M.; Zarubaev, V. V.; Orshanskaya, Ia. R.; Kadyrova, R. A.; Sannikova, V. A.; Korchagina, D. V.; Volcho, K.P.; Salakhutdinov, N. F.
    Reviews in the Neurosciences. - 2017. - Volume 27, Issue 13, pp 2920-2925 
    DOI / PubMed abstract
39. Population immunity to influenza virus A(H1N1)pdm09, A(H3N2) and B in the adult population of the russian federation long-term research results
    Konshina, O. S.; Sominina, A. A.; Smorodintseva, E. A.; Stolyarov, K. A.; Nikonorov, I. Yu
    Infektsiya i Immunitet. - 2017. - Volume 7, Issue 1, pp 27-33 
    DOI / PubMed abstract
40. Telocytes in the human sinoatrial nod
    Mitrofanova L.B.,  Gorshkov A.N. , Konovalov P.V. , Krylova J.S.
    J. Cell. Mol. Med.- 2017; Vol XX, No X; P. 1-13   
    DOI / PubMed abstract
41. Searching for new oligomycin A derivatives with improved selectivity against malignant cells
    Omelchuk, O.; Tsvetkov, V.; Dezhenkova, L.; Lysenkova, L.; Bekker, O.; Danilenko, V.; Shchekotikhin, A.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 336
    DOI / PubMed abstract
42. Comparison of different strategies for siRNA delivery against influenza A virus
    Petrova, A. V.; Bondarenko, A.; Timin, A.; Afanasev, M.; Sukhorukov, G.; Vasin, A.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 170
    DOI / PubMed abstract
43. Synthesis of vinyl thioethers and bis-thioethenes from calcium carbide and disulfides
    Rodygin, K. S.; Gyrdymova, Yu. V.; Zarubaev, V.V.
    Mendeleev Communications. - 2017. - Volume 27, Issue 5, pp 476-478
    DOI / PubMed abstract
44. 6-Nitrotriazolo[1,5-alpha]pyrimidines as Promising Structures for Pharmacotherapy of Septic Conditions
    Savateev, K. V.; Ulomsky, E. N.; Fedotov, V. V.; Rusinov, V. L.; Sivak, K. V.; Lyubishin, M. M.;  Kuzmich, N. N.; Aleksandrov, A. G.
    Russian journal of Bioorganic Chemistry. - 2017. - Volume 43, Issue 4, pp 421-428
    DOI / PubMed abstract
45. Kagocel in the therapy of influenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials
    Sologub, T. V.; Tsvetkov, V. V.
    Terapevticheskii Arkhiv. - 2017. - Volume 89, Issue 8, pp 113-119 
    DOI / PubMed abstract
46. Induction of fibrillogenesis of a number of biologically active peptides in the presence of  triazavirin
    Tsvetkov, V.; Protasov, A.; Gorshkov, A.; Shaldzhyan, A.; Mirgorodskaya, O.
    FEBS Journal. - 2017. - Volume 284. - 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, pp 193
    DOI / PubMed abstract

2016

1. Interaction Of The Dye Congo Red With Fibrils Of Lysozyme, Beta2-Microglobulin And Transthyretin
   Antimonova O.I., Grudinina N.A., Egorov V.V., Polyakov D.S., Iljin V.V., Shavlovsky M.M.*
   Cell and Tissue Biology. – 2016. – Volume 10, Issue 6, pp 468–475
   DOI / PMC Abstract
2. Biological evaluation of tetracationic compounds based on two 1,4-diazabicyclo[2.2.2]octane moieties connected by different linker
   Burakova E.A., Saranina I.V., Tikunova N.V., Nazarkina Z.K., Laktionov P.P., Karpinskaya L.A., Anikin V.B., Zarubaev V.V., Silnikov V.N.*
   Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, PP. 6012–6020
   DOI / PMC Abstract
3. Characterization of oligomerization of a peptide from the ebola virus glycoprotein by small-angle neutron scattering
   Egorov V.V., Gorshkov A.N., Murugova T.N., Vasin A.V., Lebedev D.V., Isaev-Ivanov V.V., Kiselev O.I.*
   Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 94–97
   DOI / PMC Abstract
4. On the structural features of influenza A nucleoprotein particles from small-angle X-ray scattering data
   Egorov V.V., Shaldzhyan A.A., Gorshkov A.N.,  Zabrodskaya Ya.A., Lebedev D.V., Kuklin A.I., Ksenofontova O.I., Shvetsov A.V. , Vasin A.V. et al*
   Journal of Surface Investigation. – 2016. – Volume 10, Issue 2, pp 322-325
   DOI / PMC Abstract
5. Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis
   Galochkina A.V., Anikin V.B., Babkin V.A., Ostrouhova L.A., Zarubaev V.V.*
   Archives of Virology. – 2016. – Volume 161, Issue 4, pp 929–938
   DOI / PMC Abstract
6. Functional linkage between the transport characteristics of the MDCK1 cell monolayer and their actin cytoskeleton organization
   Gorshkov A.N., Zaitseva M.R., Snigirevskaya E.S., Komissarchik Ya.Yu.*
   Cell and Tissue Biology. – 2016. – Volume 10, Issue 2, pp 133–144
   DOI / PMC Abstract
7. Modeling of conformational transitions of fibrillogenic peptide, homologous to beta-domain of human alpha-lactalbumin
   Kadochnikov V.V. Egorov V.V., Shvetsov A.V., Kuklin A.I., Isaev-Ivanov V.V., Lebedev D.V.*
   Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 98–105
   DOI / PMC Abstract
8. Model System for Multifunctionaldelivery Nanoplatforms Based On-Polymer Complexes Containing Silver Nanoparticles and Fluorescent Dye
   Kasyanenko N., Bakulev V., Perevyazko I., Nekrasova T., Nazarova O., Zolotova Y., Panarin E., Slita A.*
   Journal of Biotechnology. – 2016. – Volume 236, Pages 78–87
   DOI / PMC Abstract
9. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of 2015/2016 epidemic season in Moscow and Saint-Petersburg (Russian Federation)
   Komissarov A., Fadeev A., Petrov S., Sergeeva M., Sintsova K., Egorova A., Pisareva M., Buzitskaya Z., Musaeva T., Danilenko D., Konovalova N., Petrova P., Stolyarov K., Smorodintseva E., Burtseva E., Krasnoslobodtsev K., Kirillova E., Karpova L., Eropkin M., Sominina A., Grudinin M.*
   Influenza and Other Respiratory Viruses. – 2016. – Volume 10, Issue 4, Pages 247–253
   DOI / PMC Abstract
10. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season
    López-Labrador FX, Natividad-Sancho A, Pisareva M, Komissarov A, Salvatierra K, Fadeev A, Moya A, Grudinin M, Díez-Domingo J, Afanasieva O, Konovalova N, Sominina A, Puig-Barberà J.*
    Journal of Clinical Virology. – 2016. – Volume 84, November 2016, Pages 32–38
    DOI / PMC Abstract
11. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin
    Mardanova ES, Kotlyarov RY, Kuprianov VV, Stepanova LA, Tsybalova LM, Lomonossoff GP, Ravin NV*
    Bioengineered. – 2016. – Volume 7, Issue 1, pp 28–32
    DOI / PMC Abstract
12. Designing anti-influenza vaccines in line with the population’s genetic profile
    Onishchenko G.G., Kiselev O.I.*
    Herald of the Russian Academy of Sciences. – 2016. – Vol. 86. № 3. pp 197-205
    DOI / PMC Abstract
13. Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes
    Patrusheva OS, Zarubaev VV, Shtro AA, Orshanskaya YR, Boldyrev SA, Korchagina DV, Volcho KP, Salakhutdinov NF*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 21, Pages 5158–5161
    DOI / PMC Abstract
14. Development of a multiplex quantitative PCR assay for the analysis of human cytokine gene expression in influenza A virus-infected cells
    Plotnikova M.A., Klotchenko S.A., Vasin A.V.
    Journal of Immunological Methods. – 2016. – Volume 430, Pages 51–55
    DOI / PMC Abstract
15. Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the global influenza hospital surveillance network
    Puig-Barberà J., Burtseva E., Yu H., Cowling B.J., Badur S., Kyncl J., Sominina A., Afanasieva O., Afanasieva V., Ciblak M.A., Aktas F., Belenguer-Varea Á., Borekci S., Boza F., Buzitskaya Z., Caetano B., Cai J., Çakir B., Carballido-Fernández M. et al.*
    BMC Public Health. – 2016. – Volume 16, (Suppl 1):757
    DOI / PMC Abstract
16. Epidemiology of hospital admissions with influenza during the 2013/2014 northern hemisphere influenza season: results from the global influenza hospital surveillance network
    Puig-Barberà J., Natividad-Sancho A., Mira-Iglesias A., López-Labrador X., Trushakova S., Kisteneva L., Burtseva E., Garina E., Kolobukhina L., Krasnoslobotsev K., Merkulova L., Mukasheva E., Vartanyan R., Sominina A., Pisareva M., Stolyarov K., Afanasieva V., Buzitskaya Z., Fadeev A., Smorodintseva E. et al.*
    PLoS ONE. – 2016. – May 19;11(5):e0154970
    DOI / PMC Abstract
17. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova-Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet Infectious Diseases. – 2016. – Volume 16, Issue 3, Pages 303–310
    DOI / PMC Abstract
18. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection
    Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Salakhutdinov N.F.*
    Antiviral Chemistry and Chemotherapy. – 2016. – vol. 24, 3-4: pp. 92-98
    DOI / PMC Abstract
19. Efficiency of Canephron N in complex treatment of experimental heymann glomerulonephritis
    Sivak K.V., Lesiovskaya E.E., Stosman K.I., Savateeva-Lubimova T.N.*
    Clinical Phytoscience. – 2016. – Volume 2, Issue 1
    DOI / PMC Abstract
20. Adenosine A2A receptor as a drug target for treatment of sepsis
    Sivak KV, Vasin AV, Egorov VV, Tsevtkov VB, Kuzmich NN, Savina VA, Kiselev OI*
    Molecular Biology. – 2016. – Volume 50, Issue 2, pp 200–212
    DOI / PMC Abstract
21. Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
    Sokolova AS, Yarovaya ïI, Shernyukov áV, Baev DS, Shtro AA, Zarubaev VV, Salakhutdinov NF*
    European Journal of Medicinal Chemistry. – 2016. – Available online 19 October 2016, In Press
    DOI / PMC Abstract
22. Influence of single amino acid substitutions in the hemagglutinin on the antigenic and receptor-binding properties of influenza virus B/Florida/04/2006 of Yamagata-like evolutionary lineage
    Sorokin Evgeniy V., Tsareva Tatyana R., Sominina Anna A., Pisareva Maria M., Komissarov Andrey B., Kosheleva ánna á.
    Microbiology Independent Research Journal . – 2016. – Volume 3, Number 1, pp 56-60
    DOI / PMC Abstract
23. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity
    Stepanova L.A., M. V. Sergeeva, M. A. Shuklina, A. A. Shaldzhyan, M. V. Potapchuk, A. V. Korotkov, L. M. Tsybalova
    Acta Naturae. – 2016. – Vol. 8, № 2(29)
    DOI / PMC Abstract
24. Interaction between cationic agents and small interfering RNA and DNA molecules
    Unksov I.N., Slita A.V., Petrova A.V., Pereviazko I., Bakulev V.M., Rolich V.I., Bondarenko A.B., Kasyanenko N.A.*
    Journal of Physics: Conference Series. – 2016. – Volume 769, Number 1
    DOI / PMC Abstract
25. The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure
    Vasin A.V., Petrova A.V., Egorov V.V., Plotnikova M.A., Klotchenko S.A., Karpenko M.N., Kiselev O.I.*
    BMC Research Notes. – 2016. – (9):(279)
    DOI / PMC Abstract
26. Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: an in vitro study
    Zarubaev VV., Morkovnik AS, Divaeva LN, Karpinskaya LA, Borodkin GS*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, Pages 5796–5803
    DOI / PMC Abstract
27. Main Aetiological Features of Acute Respiratory Viral Diseases in Young People of Draft Age and Conscripts During the 2013-2014 Epidemic Season
    Zhdanov K., Lvov N., Maltsev O., Peredelsky E. and Pisareva M.*
    International Review of the Armed Forces Medical Services. – 2016. – V. 89/2. - 58-63
    DOI / PMC Abstract

2015

1. Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
   Kiselev O.I., Vasin A.V., Deeva E.G., Sivak K.V., Egorov V.V., Tsvetkov V.B., Egorov A.Y., Romanovskaya-Romanko E.A., Stepanova L.A., Komissarov A.B., Tsybalova L.M., Ignatjev G.M., Shevyryova M.P.*
   Molecular Biology [Moscow].  – 2015. – Vol.49, № 4. – P. 480-493. [English version]
2. Peptide-induced amyloid conformational transitions in proteins
   Egorov  V., Grudinina  N., Vasin A., Lebedev D.
   International Journal of Peptides. – 9/2015 (2015). Article ID 723186, 5 pp.
3. Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray
   Heydarov R.N., Fesenko E.E., Shaskolskiy B.L., Titov S.V., Dementieva E.I., Zasedatelev A.S., Mikhailovich V.M., Klotchenko S.A., Vasin A.V., Kiselev O.I.*
   Doklady. Biochemistry and Biophysics. – 2015. – Vol.460, № 1. – P. 4-8. [English version]
   Epub 2015 Mar 13.
   doi: 10.1134/S1607672915010032.
4. Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins
   Rusinov V.L., Sapozhnikova I.M., Ulomskii E.N., Medvedeva N.R., Egorov V.V., Kiselev O.I., Deeva E.G., Vasin A.V., Chupakhin O.N.*
   Chemistry of Heterocyclic Compounds. – 2015. – Vol. 51, Issue 3. – P.275–280. [English version]
   Epub 2015 Apr 16.
5. Regulatory role of small nucleolar RNAs in human diseases
   Stepanov G.A., Filippova J.A., Kuligina E.V., Richter V.A., Semenov D.V., Komissarov A.B., Tang T.H.*
   Biomed Research International. – 2015. – ID 206849, 10 pp.
6. Synthesis  and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments
   Matusevich O.V., Egorov V.V., Gluzdikov I.A., Titov M.I., Zarubaev V.V., Shtro A.A., Slita A.V., Dukov M.I., Shurygina A.-P., Smirnova T.D., Kudryavtsev I.V., Vasin A.V., Kiselev O.I.*
   Antiviral Research. – 2015. – Vol. 113. – P.4-10.
   doi: 10.1016/j.antiviral.2014.10.015. Epub 2014 Nov 12.
7. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo
   Zarubaev V.V., Garshinina A.V., Tretiak T.S., Fedorova V.A., Shtro A.A., Sokolova A.S., Yarovaya O.I., Salakhutdinov N.F.
   Antiviral Research. – 2015. – Vol. 120. – P.126-133.
   doi: 10.1016/j.antiviral.2015.06.004. Epub 2015 Jun 10.
8. Discovery of a new class of antiviral compounds: Camphor imine derivatives
   Sokolova A.S. , Yarovaya O.I., Shernyukov A.V., Gatilov Y.V., Razumova Y.V., Zarubaev V.V.,  Tretiak T.S.,  Pokrovsky A.G., Kiselev O.I., Salakhutdinov N.F.*
   European Journal of Medical Chemistry. – 2015. – Vol.105. – P.263-273.
   doi: 10.1016/j.ejmech.2015.10.010. Epub 2015 Oct 22.
9. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors
   Baltina L.A. Jr., Zarubaev V.V., Baltina L.A., Orshanskaya I.A., Fairushina A.I., Kiselev O.I., Yunusov M.S.*
   Bioorganic & Medicinal Chemistry Letters. – 2015. – Vol. 25, № 8. – P.1742-1746.
   doi: 10.1016/j.bmcl.2015.02.074. Epub 2015 Mar 7.
10. Synthesis and antiviral activity of quercetin brominated derivatives
    Karimova E., Baltina L., Spirikhin L., Gabbasov T., Orshanskaya Y., Zarubaev V.
    Natural Product Communications. – 2015. – Vol. 10, № 9. – P.1565-1568.
11. New  carbocyclic N6-substituted adenine and pyrimidine nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, antiviral, anticancer activity and X-ray crystallography
    Tănase C.I., Drăghici C., Cojocaru A., Galochkina A.V., Orshanskaya J.R., Zarubaev V.V., Shova S., Enache C., Maganu M.*
    Bioorganic & Medicinal Chemistry. – 2015. – Vol. 23, № 19. – P.6346-6354.
    doi: 10.1016/j.bmc.2015.08.033. Epub 2015 Sep 1.
12. Search for antiviral agents among quinopimaric acid scaffold derivatives
    Vafina G.F.,  Uzbekov A.R., Zarubaev V.V., Karpinskaya L.A., Shtro A. A., Yunusov M.S.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 1. – P.103-107. [English version]
13. Activity of Thermopsis schischkinii alkaloids against influenza A(H1N1)pdm09 virus
    Tsypysheva I.P., Galkin E.G., Baikova I.P., Fedorov N.I., Petrova P.R.,.Orshanskaya Ya.R., Fedorova V.A., Zarubaev V.V.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 5. – P.1003-1005.
    Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin
    Stepanova L.A., Kotlyarov R.Y., Kovaleva A.A., Potapchuk M.V., Korotkov A.V., Sergeeva M.V., Kasianenko M.A., Kuprianov V.V., Ravin N.V., Tsybalova L.M., Skryabin K.G., Kiselev O.I.*
    PLoS One. – 2015. – Vol. 10, № 3. – e0119520.
    doi: 10.1371/journal.pone.0119520
14. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.
    BMC Biotechnology. – 2015. – Vol. 15. – 42.
    doi: 10.1186/s12896-015-0164-6.
15. High immunogenicity of plant-produced influenza based on the M2e peptide fused to flagellin
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.*
    Bioengineered. – 2015. – Dec 28:0. [Epub ahead of print]
    doi: 10.1186/s12896-015-0164-6.
16. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency
    Ravin N.V., Blokhina E.A., Kuprianov V.V., Stepanova L.A., Shaldjan A.A., Kovaleva A.A., Tsybalova L.M., Skryabin K.G.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3392–3397.
    doi: 10.1016/j.vaccine.2015.04.066. Epub 2015 Apr 29.
17. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e
    Tsybalova L.M., Stepanova L.A., Kuprianov V.V., Blokhina E.A., Potapchuk M.V., Korotkov A.V., Gorshkov A.N., Kasyanenko M.A., Ravin N.V., Kiselev O.I.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3398–3406.
    doi: 10.1016/j.vaccine.2015.04.073. Epub 2015 May 11.
18. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double- blind phase 1 study
    Rudenko L., Kiseleva I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Larionova N., Pisareva M., Krivitskaya V., Flores J.; Russian LAIV Trial Study group*
    Vaccine. – 2015. – Vol. 33, № 39. – P.5110-5117. -
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
19. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses
    Kiseleva I., Dubrovina I.,  Fedorova E., Larionova N., Isakova-Sivak I., Bazhenova E., Pisareva M., Kuznetsova V., Flores J., Rudenko L.*
    Vaccine. – 2015. – Vol. 33, № 49. – P.7008-7014.
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
20. H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
    Isakova-Sivak I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Petukhova G.,  Kuznetsova V.,  Kiseleva I.,  Smolonogina T., Dubrovina I.,  Pisareva M.,  Nikiforova A.,  Power M., Flores J., Rudenko L.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 4. – P.970- 982. -
    doi: 10.1080/21645515.2015.1010859.
21. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
    Rudenko L., Naykhin A.,  Donina S.,  Korenkov D., Petukhova G.,  Isakova-Sivak I., Losev I., Stukova M.,  Erofeeva M.,  Nikiforova A.,  Power M., Flores J.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 12. – P.2839-2848.
    doi: 10.1080/21645515.2015.1069931.
22. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova- Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet. Infectious Diseases. – 2015. – Dec. 7. Pii: S1473-3099 (15)00378-3.
    doi: 10.1016/S1473-3099(15)00378-3. [Epub ahead of print].
23. A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice
    Kittel C., Wressnigg N., Shurygina A.P., Wolschek M., Stukova M.,  Romanovskaya-Romanko E., Romanova J., Kiselev O., Muster T., Egorov A.
    Archives of Virology. – 2015. – Vol. 160, № 10. – P.2525- 2534.
    doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.
24. Mutations in human genes that increase the risk for severe influenza infection
    Kiselev O. I., Komissarov A. B., Konshina O.S , Dmitrieva M.N., Deyeva E.G., Sologub T.V., Pokrovskiy V.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
25. Changes in the antigenic and genetic structure of influenza viruses: analysis of surveillance data of influenza A and B in Russia in 2006-2013
    Grudinin M.P., Pisareva M.M., Komissarov A.B., Kosheleva A.A., Buzitskaya J.V., Stukova M.A., Prokopetz A.V., Danilenko D.M., Konovalova N.I., Lobova T.G., Sominina A.A., Kiselev O.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
26. Two years of experience in hospital surveillance for the severe influenza like illnesses in St. Petersburg: etiology, clinical characterization of diseases, antigenic and genetic properties of isolated influenza viruses
    Sominina A.A., Pisareva M. M., Grudinin M.P., Eropkin M.Yu., Konovalova N.I, Sukhovetskaya V.F., Afanasieva O.I., Voloshuk L.V., Komissarov A.B., Buzitskaya Z.V., Fadeev A.V., Stolyarov K.A., Smorodintseva E.A., Afanasieva V.S., Yanina M.A., Gonchar V.V., Osidak L.V., Go A.A.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
27. The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza
    Puig- Barberà  J., Tormos A.,Trushakova  S., Sominina  A., Pisareva M. et al.
    Influenza and Other Respiratory Viruses. – 2015.  – Vol. 9, Issue 6. – P.277–286.
    doi: 10.1111/irv.12335
28. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region – an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases
    Meerhoff T.J., Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, Chakhunashvili G, Karseladze I, Yesmagambetova A, Kuatbayeva A, Nurmatov Z, Otorbaeva D, Lupulescu E, Popovici O, Smorodintseva E, Sominina A, Holubka O, Onyshchenko O, Brown CS, Gross D.*
    BMC Infectious Diseases. – 2015. – Vol. 15. – 1.
    doi: 10.1186/s12879- 014-0722-x.
29. Nanosolutions
    Lyubchik S., Lyubchik A., Makarova T., Eropkin M.
    International Innovation. – 2015. – Issue 187. - P. 31-33.
30. Physicochemical molecular, and biological properties of complexes formed between aminoglycoside antibiotics and some anionic copolymers of acrylic series: Part II
    Tarabukina E.B., Solovskii M.V., Pautov V.D., Amirova A.I., Zahkarova N.V., Smirnova M.Y., Anan’eva T.D., Imanbaev R.T., Eropkin M.Y., Eropkina E.M.*
    Journal of Bioactive and Compatible Polymers: Biomedical Applications. – 2015. – Vol.30, № 6. – P.571-583.
    Epub July 6, 2015 doi:10.1177/0883911515592258.

Books and proceedings:

Abstracts of the 18th Annual Meeting of European Society for Clinical Virology, 9th–12th September 2015, Edinburgh // Journal of Clinical Virology. – Vol.70, Suppl.1.

• Effect of single amino acid substitutions in the hemagglutinin on the receptor-binding properties of influenza B viruses
  Sorokin E., Tsareva T., Sominina A., Pisareva M., Komissarov A., Kosheleva A. – P.S29 (Abstr. № 1502).
• Influenza in Russia in the season 2014–2015: Epidemiology and antigenic properties of viruses
  Eropkin M., Karpova. L., Konovalova N., Lobova T., Petrova P., Eropkina E., Schekanova S., Sominina A. – P.S30 (Abstr. № 1503).
• Virus etiology of SARI cases and protective role of influenza vaccination determined in sentinel surveillance system
  Smorodintseva E., Sominina A., Stolyarov K., Sysoeva T. – P.S30 (Abstr. № 1504).

2014

Research papers:

1. Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins
   Vasin A.V., Temkina O.A.,  Egorov V.V., Klotchenko S.A., Plotnikova M.A., Kiselev O.I.
   Virus Research. – 2014. – Vol. 185. – P.53-63.
   doi: 10.1016/j.virusres.2014.03.015. Epub 2014 Mar 24.
2. Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector
   Kuznetsova I., Shurygina A.P., Wolf B., Wolschek M., Enzmann F., Sansyzbay A., Khairullin B., Sandybayev N., Stukova M., Kiselev O., Egorov A., Bergmann M.*
   Journal of General Virology. – 2014. – Vol.95, pt.2. – P.337-349.
   doi: 10.1099/vir.0.056036-0. Epub 2013 Nov.12.
3. A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis
   Egorov V.V., Lebedev D.V., Shaldzhyan A.A., Sirotkin A.K., Gorshkov A.N., Mirgorodskaya O.A., Grudinina N.A., Vasin A.V., Shavlovsky M.M. *
   Prion. – 2014. – Vol.8, 5. – P.369-373.
   doi: 10.4161/19336896.2014.983745.
4. Comparative evaluation of effectiveness of IAVchip DNA microarray in influenza A diagnosis
   Sultankulova K.T., Chervyakova O.V., Kozhabergenov N.S., Shorayeva K.A., Strochkov V.M., Orynbaev M.B., Sandybayev N.T., Sansyzbay A.R., Vasin A.V.*
   Scientific World Journal. – 2014. – (2014). – ID 620580. – 11 pp.
   doi: 10.1155/2014/620580. Epub 2014 Nov.23.
5. The use of inducers of apoptosis in treatment of experimental influenza infection and prevention of chronic postinfluenza lung lesions
   Zarubaev V. V., Tribulovich V. G., Belyaevskaya S. V.,  Barlev N.A.*
   Cell and Tissue Biology. – 2014. – Vol.8, Issue 4. – P.344-351.
   (Original version: Tsitologiya. – 2014. – Vol.56, 3. – P.241-247.)
6. Camphor-based symmetric diimines as inhibitors of influenza virus reproduction
   Sokolova A.S. , Yarovaya O.I., Korchagina D.V.,  Zarubaev V.V.,  Tretiak T.S.,  Anfimov P.M. , Kiselev O.I., Salakhutdinov N.F. *
   Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 7. – P.2141-2148.
   doi: 10.1016/j.bmc.2014.02.038. Epub 2014 Mar 1.
7. Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus
   Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Kiselev O.I., Salakhutdinov N.F.*
   Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 24. – P.6826-6836.
   doi: 10.1016/j.bmc.2014.10.033. Epub 2014 Oct 31.
8. Synthesis and antiviral activity of bis-spirocyclic derivatives of rhodanine
   Kurbatov S.V., Zarubaev V.V., Karpinskaya L.A., Shvets A.A., Kletsky M.E., Burov O.N., Morozov P.G., Kiselev O.I., Minkin V.I. *
   Russian Chemical Bulletin. – 2014. – Vol.63, Issue 5. – P.1130-1136.
   (Original version: Izvestiya Akademii Nauk.Ser. Khimicheskaya – 2014. – 5. – P.1130-1136.)
9. New amino-acid conjugates of glycyrrhizic acid
   Baltina L.A. Jr., Stolyarova O.V., Baltina L.A., Kondratenko R.M., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V.*
   Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 2. – P.317-320.
10. Synthesis and antiviral activity of amino-acid conjugates of glycyrrhetic acid
    Baltina L.A. Jr., Khudobko M.V., Mikhailova L.R., Baltina L.A., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V., Kiselev O.I.*
    Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 3. – P.473-477.
11. Porous silicon and its applications in biology and medicine
    Ksenofontova O. I., Vasin A.V., Egorov V.V., Kiselev. O.I., Bobyl A.V., Soldatenkov F.Yu., Terukov E.I., Ulin V.P., Ulin N.V.*
    Technical Physics. The Russian Journal of Applied Physics.  – 2014. – Vol. 59, Issue 1. – P. 66-77.
    (Original version: Zhurnal Tekhnicheskoi Fiziki, – 2014. – Vol.84, 1. – P.67-78.)
12. Photodynamic inactivation of enveloped virus in protein plasma preparations by solid-phase fullerene-based photosensitizer
    Belousova I.M.,  Kislyakov I.M., Muraviova T.D., Starodubtsev A.M., Kris’ko T.K. , Selivanov E.A. , Sivakova N.P., Golovanova I.S., Volkova S.D., Shtro A.A.,  Zarubaev V.V. *
    Photodiagnosis and Photodynamic Therapy. –  2014. – Vol.11, Issue 2. – P.165-170.
    doi:10.1016/j.pdpdt.2014.02.009
13. Recombinant strain A/HK/Otar/6:2/2010 (H3N8) for development of a live intranasal equine influenza vaccine
    Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sultankulova K.T., Sandybayev N.T., Sansyzbay A.R., Gorev N.A., Sergeeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.*
    Journal of Equine Veterinary Science. – 2014. – Vol.34, Issue 6. – P.749-758.
14. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo–controlled, randomized double–blind phase I study of live attenuated H7N3 influenza vaccine
    Rudenko L., Kiseleva I., Naykhin A., Erofeeva M., Stukova M., Donina S., Petukhova G., Pisareva M., Krivitskaya V., Grudinin M., Buzitskaya Zh., Isakova-Sivak I., Kuznetsova S., Larionova N.,  Desheva J., Dubrovina I., Nikiforova A., Victor J., Neuzil K., Flores J., Tsvetnitsky V., Kiselev O.*
    PLoS One. – 2014. – Vol. 9, 2. – e87962.
    doi: 10.1371/journal.pone.0087962
15. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network
    Puig-Barberà J., Natividad-Sancho A., Launay O., Burtseva E., Ciblak M.A.,  Tormos A., Buigues-Vila A., Martinez-Ubeda S., Sominina A.; GIHSN Group*
    PLoS One. – 2014. – Vol. 9, 6. – e100497. (Correction: PLoS One. – 2014. – Vol. 9, 9. – e107849.)
    doi: 10.1371/journal.pone.0100497.
16. Evidence of specialized tissue in human interatrial septum: histological, immunohistochemical and ultrastructural findings
    Mitrofanova L.B., Gorshkov A.N., Lebedev D.S., Mikhaylov E.N.*
    PLoS One. – 2014. – Vol. 9, 11. – e113343.
    doi: 10.1371/journal.pone.0113343.
17. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season
    Puig-Barberà J., Tormos A.,  Sominina A., Burtseva E., Launay O., Ciblak M.A., Natividad-Sancho A., Buigues-Vila A., Martinez-Ubeda S., Mahe C.; GIHSN Group*
    BMC Public Health. – 2014. – Vol. 14. – 564.
    doi: 10.1186/1471-2458-14-564.
18. Vitreous films of Ga₆Ge₁₇S₄₃ composition as a biochip substrate
    Vasil’eva A.S., Borisov E.N., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.467-469.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.615-618.)
19. As₃₉S₆ films as protein-selective two-dimensional arrays for biochips
    Vasil’eva A.S., Belykh A.V., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.470-471.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.619-621.)
20. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines
    Nakowitsch S., Waltenberger A.M., Wressnigg N., Ferstl N., Triendl A., Kiefmann B., Montomoli E., Lapini G., Sergeeva M.,  Muster T., Romanova J.R.
    Biotechnology Journal. – 2014. – Vol.9, Issue 3. – P. 405-414.

Books and proceedings:

• Human Endogenous Retroviruses, Placenta and Immunosuppression
  O.I. Kiselev
  St. Petersburg, 2014, Rostok, 320 p.

The Fifth ESWI Influenza Conference, Riga, Latvia, September 14–17, 2014:

• Comparative Analysis of MariPOC System And RRT-PCR in Detection of Influenza a Virus in Clinical Samples
  Petrova, Ekateria; Krivitskaya, Vera; Pisareva, Maria; Buzitskaya, Zhanna; Sukhovetskaya, Vera; Danilenko, Daria; Suddenkova, Polina; Sominina, Anna A.
  SPA1P06
• Epitope Mapping of the Hemagglutinin Molecule of Influenza B/Yamagata And B/Victoria Lineage Viruses Using Monoclonal Antibodies
  Sorokin, Evgenii; Tsareva, Tatiana; Sominina, Anna A.; Pisareva, Maria; Komissarov, Andrei; Kosheleva, Anna
  SPB5P08
• Host-specific Distribution of (+)-RNA Secondary Structures in Segment 8 of Influenza A Viruses
  Vasin, Andrey; Petrova, Alexandra; Plotnikova, Marina; Klotchenko, Sergey; Egorov, Vladimir; Kiselev, Oleg
  SPB5P02
• Influenza Epidemic Season 2013-2014 in Russia: Characteristics of Isolated Strains
  Eropkin, Mikhail; Danilenko, Daria; Konovalova, Nadejda; Komissarov, Andrey; Pisareva, Maria; Grudinin, Mikhail; Lobova, Tamara; Schekanova, Svetlana; Kornilova, Ekaterina; Eropkina, Elena; Suddenkova, Polina
  SPA2P04
• Some Approaches to Prediction of Seasonal Influenza Epidemic Burden
  Sominina, Anna A.; Karpova, Ludmila; Smorodintseva, Elizaveta; Grudinin, Mikhail; Pisareva, Maria; Komissarov, Andrei; Eropkin, Mikhail; Konovalova, Nadejda; Danilenko, Daria
  SPA2P12
• Molecular Peculiarities of Influenza A and B Viruses Circulating in Russia During Two Epidemic Seasons in 2012-2014
  Komissarov, Andrey; Kosheleva, Anna; Fadeev, Artem; Elpaeva, Ekaterina; Mikhailova, Maria; Pisareva, Maria; Buzitskaya, Janna; Stukova, Marina; Danilenko, Daria; Konovalova, Nadejda; Eropkin, Mikhail; Grudinin, Mikhail
  SPB5P05
• Hospitalizations with Influenza in the Northern Hemisphere 2013-2014 Influenza Season. Results from the Global Influenza Hospital Surveillance Network
  Puig-Barberà, Joan; Tormos, Anita Marie Catherine; Sominina, Anna; Ciblak, Meral; Mira-Iglesias, Ainara; Natividad-Sancho, Angels; Buigues-Vila, Amparo; Burtseva, Elena
  SPA1P03

4th International Influenza Meeting, Muenster, Germany, September 21–23, 2014:

• Infection of primary endometrium cells with influenza A(î3N2) virus can cause their functional dysregulation
  Danilenko D.M., Smirnova T.D., Pisareva M.M., Durnova A.O., Kadirova R.A., Smirnova S.S.*
  Abstr.P15. – P.62.
• Antiviral and cytoprotective activity of Influcid® in cell cultures model systems
  Eropkin M., Eropkina E., Bryazhikova T.
  Abstr.P23. – P.70.
• Influenza surveillance in swine in North-Western region of Russia
  Komissarov A.B., Konovalova N.I., Fadeev A.V., Sintsova K.S., Palaziuk S.V., Aliev A.S., Danilenko D.M., Eropkin M.Yu., Grudinin M.P.*
  Abstr.P51. – P.98.
• A new aspect of influenza virus pathogenesis
  Azarenok A.A., Prochukhanova A.R., Ilynskaya E.V., Zenin V.V., Lublinskaya O.G., Eropkina E.M., Zhilinskaya I.N.
  Abstr.P74. – P.121.
• Immunogenicity graphs as a method of assessment and comparison of viruses in the contemporary influenza vaccine
  Voytsehovskaya E.M., Vasilyeva A.A., Kuznetsova E.V., Vakin V.S., Sominina A.A.
  Abstr.P108. – P.155.

17th Annual Meeting of the European Society for Clinical Virology (ESCV), Prague, Czech Republic, September 27–October 1, 2014:

• A novel automated mariPOC® detection test detects well current and emerging inluenza A virus subtypes
  Koskinen J., Sominina A.A., Krivitskaya V. Z., Voycekhovskaya E.V., Toivola H., Koskinen J.O.*
  Abstr.P01. – ID 63.

2013

Research papers:

1. Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012
   Sominina A., Burtseva E., Eropkin M., Karpova L., Zarubaev V., Smorodintseva E., Konovalova N., Danilenko D., Prokopetz A., Grudinin M., Pisareva M., Anfimov P., Stolyarov K., Kiselev O., Shevchenko E., Ivanova V., Trushakova S., Breslav N., Lvov D., Klimov A., Moen A., Cox N. *
   American Journal of Infectious Diseases. – 2013. – Vol.9, № 3. – P.77-93
2. Transmission studies resume for avian flu
   Fouchier R.A., Garcia-Sastre A., Kawaoka Y., …… Kiselev O.I., et al.*
   Science. – 2013. – Vol.339, № 6119. – P.520-521.
   doi: 10.1126/science.1235140. Epub 2013 Jun 23.
3. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
   Koel B.F., Burke D.F., Bestebroer T.M., ………. Eropkin M.Y., et al.*
   Science. – 2013. – Vol.342, № 6161. – P.976-979.
   doi: 10.1126/science.1244730. Epub 2013 Jun 23.
   Structural features of the peptide homologous to 6-25 fragment of influenza A PB1 Protein
   Egorov V.V., Matusevich O.V., Shaldzhyan A.A., Skvortsov A.N., Zabrodskaya Ya.A., Garmay Yu.P., Landa S.B., Lebedev D.V., Zarubayev V.V., Sirotkin A.K., Vasin A.V., Kiselev O.I. *
   International Journal of Peptides. – 2013. – Vol. 2013. – ID 370832. – 5 pp. http://dx.doi.org/10.1155/2013/370832
4. Amyloidogenic peptide homologous to fragment 129-148 of human myocilin
   Egorov V.V., Grudinina N.A., Lebedev D.V., Shaldzhyan A.A., Slita A.V., Sirotkin A.K., Vasin A.V., Shavlovsky M.M.*
   Prion. – 2013. – Vol. 7, № 3. – P.248-252.
   doi: 10.4161/pri.24239.
5. Magnetic labeling of proteins for atomic force microscopy
   Egorov V.V., Zabrodskaya Y.A., Kalinin A.S., Lebedev D.V., Grudinina N.A., Vasin A.V., Kolikov V.A., Klotchenko S.A., Shawlovsky M.M., Rutberg P.G. *
   Doklady. Biochemistry and Biophysics. – 2013. – Vol.448, Issue 1. – P.33-35.
   doi: 10.1134/S1607672913010080. Epub 2013 Mar 13.
   (Original version: Doklady Akademii Nauk. – 2013. – Vol.448, № 4. – P.477-479.)
6. An inactivated adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans
   Sansyzbay A.R., Erofeeva M.K., Khairullin B.M., Sandybaev N.T., Kydyrbaev Z.K., Mamadaliyev  S.M., Kassenov M.M., Sergeeva M.V., Romanova J.R., Krivitskaya V.Z., Kiselev O.I., Stukova M.A. *
   Clinical and Vaccine Immunology. – 2013. – Vol.20, № 8. – P.1314-1319.
   doi: 10.1128/CVI.00096. Epub 2013 Jun 26.
7. The use of transient expression systems for the rapid production of virus-like particles in plants
   Thuenemann E.C., Lenzi P., Love A.J., Taliansky M., Bécares M., Zuñiga S., Enjuanes L., Zahmanova G.G., Minkov I.N., Matić S., Noris E., Meyers A., Hattingh A., Rybicki E.P., Kiselev O.I., Ravin N.V.*
   Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5564-5573. [Review.]
8. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by tobacco mosaic virus-based vectors
   Petukhova N.V., Gasanova T.V., Stepanova L.A., Rusova O.A., Potapchuk M.V., Korotkov A.V., Skurat E.V., Tsybalova L.M., Kiselev O.I., Ivanov P.A., Atabekov J.G.*
   Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5587-5600. doi:10.2174/13816128113199990337
9. Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus
   Dukhovlinov I., Al-Shekhadat R., Fedorova E., Stepanova L., Potapchuk M., Repko I., Rusova O., Orlov A., Tsybalova L., Kiselev O.
   Medical Science Monitor Basic Research. – 2013. – Vol.19. – P.221-227.
   doi:10.12659/MSMBR.884002
10. Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A(H1N1)pdm09
    Teplov G.V., Suslov E.V., Zarubaev V.V., Shtro A.A., Karpinskaya L.A., Rogachev A.D., Korchagina D.V.,
    Volcho K.P., Salakhutdinov N.F., Kiselev O.I.*
    Letters in Drug Design & Discovery. – 2013. – Vol. 10, № 6. –  P.477-485.
11. New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity
    Sokolova A.S., Yarovaya C.O., Shernyukov C.A., Pokrovsky C.E., Pokrovsky C.A., Lavrinenko V.A., Zarubaev V.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Beklemishev A.B., Salakhutdinov N.F.
    Bioorganic and Medicinal Chemistry. – 2013. – Vol.21, Issue 21. – P.6690-6698.
    doi: 10.1016/j.bmc.2013.08.014. Epub 2013 Aug 12.
12. The search for new drugs synthesis and antiviral activity of derivatives of meristotropic and macedonic acids
    Zarubaev V.V., Kiselev O.I.,  Shtro A.A., Zorina A.D., Balykina L.V., Esipenko N.A., Anokhina V.V., Bukkreeva T.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.46, № 10. – P.579-583.
    (Original version: Khim.-Pharm.Journ. – 2012. – Vol.46, № 10. – P.3-7.)
13. Synthesis and biological activity of fullerenols with various contents of hydroxyl groups
    Eropkin M.Y., Bryazzhikova T.S., Eropkina E.M., Danilenko D.M., Kiselev O.I., Melenevskaya E.Y., Nasonova  K.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.47, № 2. – P.87-91.
    (Original version: Khim.-Pharm.Journ. – 2013. – Vol.47, № 2. – P.19-23.)
14. Phylogenetic analysis of six-domain multi-copper blue proteins
    Vasin A.V., Klotchenko S.A., Puchkova L.V.
    PLoS Curr. 2013 Mar 13;5.
15. Current Methods of Human and Animal Brucellosis Diagnostics
    Smirnova E., Vasin A., Sandybaev N., Klotchenko S., Plotnikova M., Chervyakova O., Sansyzbay A., Kiselev O.
    Advances in Infectious Diseases. – 2013 – V. 3. – N. 3. – P.177-184
16. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
    Blokhina E.A., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Kiselev O.I., Ravin N.V., Skryabin K.G.*
    Virology. – 2013. – Vol. 435, № 2. – P.293-300.
     doi: 10.16/j.virol.2012.09.014. Epub 2012 Oct 11.
17. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
    Venanzi F., Shifrin V., Sherman M., Gabai V., Kiselev O.,  Komissarov A., Grudinin M., Shartukova M., Romanovskaya-Romanko E.A., Kudryavets Y., Bezdenezhnykh N., Lykhova O., Semesyuk N., Concetti A., Tsyb A., Filimonova M., Makarchuk V., Yakubovsky R., Chursov A., Shcherbinina V., Shneider A.*
    Oncotarget. – 2013. – Vol.4, № 10. – P.1829-1835.

Books and proceedings:

• Neurochemical Methods of Investigations in the Clinic
  V.K. Pozdeev, N.V. Pozdeyev
  St. Petersburg, 2013, Renome, 312 p.
• Essays on Nanomedicine
  L.B. Piotrovskiy
  edited by O.I. Kiselev
  St. Petersburg, 2013, Evropeyskiy Dom, 204 p.
• Chronic Viral Hepatitis B: Diagnosis and Clinical Features
  O.P. Dudanova, O.I. Kiselev
  Petrozavodsk, 2013, 112 p.

7th Vaccine & ISV óongress 2013, Barcelona, Spain, October 27–29, 2013:

• Protective properties of inactivated virosomal influenza vaccine
  Erofeeva í.ë., Nickonorov I.J., Maksakova V.L., Stukova M.A., Konshina O.S., Okhapkina E.A., Voicehovskaya E.M., Korovkin S.A., Melnikhov S.J., Kiselev O.I.
• High specific activity of the vaccine preparation comprising recombinant protein with 4 copies of the influenza virus M2e
  Tsybalova L., Stepanova L., Kupriyanov V., Potapchuk M., Korotkov A., Ravin N.

5th European Congress of Virology, Lyon, France, September, 11–14 2013:

• Multiplicity of infection determines cell fate in human monolayer cell cultures after influenza A virus infection
  Danilenko D.M., Smirnova T.D., Eropkin M. Yu.
• Antiviral and cytoprotective activities of fullerenols with the different content of hydroxyl groups
  Eropkin M.Yu., MelenevskayÁ E., Bryazhikova T., Eropkina E., Danilenko D.M.

Options for the control of influenza VIII, Cape Town, South Africa, September 5–10, 2013:

• Potential Use of Rat Polyclonal Antisera for Antigenic Analysis of Human Influenza Viruses
  Danilenko D.M., Konovalova N.I., Eropkin M. Yu., Smith D.J., Russell C.A.
• Drug resistance of influenza virus strains circulated in Russia during four epidemic seasons 2009-2010, 2010-2011, 2011-2012 and 2012-2013
  P.M. Anfimov, A.A. Sominina, V.V. Zarubaev, M.P. Grudinin, M.Y. Eropkin, O.I. Kiselev
• Antiviral activity of usnic acid derivatives against influenza virus in vivo
  A.A. Shtro, O.A. Luzina, M.P. Polovinka, D. N. Sokolov, N. I. Komarova, N. F. Salakhutdinov, O. I. Kiselev, V.V. Zarubaev
• Novel class of low molecular anti-influenza agents based on camphor pharmacophore
  Zarubaev V.V., Sokolova A.S., Yarovaya O.I., Shernyukov A.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Salakhutdinov N.F.
• Molecular genetic characterization of influenza A and B virus strains circulated in Russia in 2010-2013
  Mikhail Grudinin, Anna Kosheleva, Andrey Komissarov, Artem Fadeev, Maria Pisareva, Janna Buzitskaya, Marina Stukova, Oleg Kiselev
• Main factor of the low antigen content of inactivated H5N1 influenza vaccines – decreased stability of the H5 hemagglutinin protein
  Sergeeva M.V., Krokhin A.A., Tsybalova L.M., Romanova J.R.

“Mechanisms in Biology” 38th Federation of European Biochemical Societies Congress, St. Petersburg, Russia, 6–11 July, 2013:

• Molecular mechanisms enhancing the coding potential of RNA genome of influenza A viruses
  Vasin A., Temkina O., Klotchenko S., Plotnikova M., Egorov V., Kiselev O.
• Short peptides which enhance the fibrillogenesis of the model peptide
  Egorov V., Shaldzhyan A., Sirotkin A., Mirgorodskaya O., Vasin A., Lebedev D., Shvetsov A., Grudinina N., Shavlovsky M.
• Development of multiplex real-time PCR for quantification of cytokines mRNA expression in influenza virus infected human cells
  Plotnikova M., Vasin A.
• In silico analysis of the conserved regions with stable secondary structure within the NS gene of human influenza A viruses
  Klotchenko S., Brodskaya A., Temkina O., Vasin A.
• Mechanisms of immunosuppression in viral infections: From retroviruses to Ebola and influenza viruses
  Kiselev O.
• Thiol-disulfide system as universal biomarker for personalized therapy of infectious diseases and cancer
  Volchek I., Sologub T., Petrov A.

2012

Research papers:

1. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009
   Sokolov D. N., Zarubaev V. V., Shtro A. A., Polovinka M. P., Luzina O. A., Salakhutdinov N. F., Kiselev O. I.
   Bioorg Med Chem Lett. – 2012. – V. 22. – ò.7060-7064
2. The European Virus Archive: A new source for virology research
   Gould E.A., de Lamballerie X., Goutard B., Eropkin M. et al.
   Antiviral Res. – 2012. – V.95. – N2. – P. 167-171.
3. Controlled trypsinolysis of human cancer and non-cancer sera for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
   Toropygin I.Yu., Mirgorodskaya O.A., Moshkovskii S.A., Serebryakova M.V., Archakov A.I.
   International Journal of Mass Spectrometry. – 2012. – V.325-327. – P.121-129
4. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice
   Tarasov S.A., Zarubaev V.V., Gorbunov E.A., Sergeeva S.A, Epstein O.I.
   Antiviral Res. – 2012. – V.93. – N2. – P. 219-224
5. Dynamic of Cell Population Structure in Liver Biopsy of the Patients with Chronic Hepatitis Viral Infection
   Tokin I.B., Filimonova G., Tokin I.I., Hussar P.
   Papers on Anthropology. – 2012. – V. XXI. – P. 276-286
6. New recombinant strain A/HK/Astana/6:2/2010 for prophylaxis of A/H5N1 influenza
   Sultankova K.T., Sandybaev N.T., Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sanayzbay A.R., ïrynbaev M.B., Gorev N.E., Sergeyeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.
   Biotechnology Research Bulletin. – 2012. – V.1. – P.005-014

Books and proceedings:

• Virology Textbook
  A.V. Pinevich, A.K. Sirotkin, O.V. Gavrilova, A.A. Potekhin
  St. Petersburg State University, 2012, 432 p.
• Chronic Viral Hepatitis C: Diagnosis and Clinical Features
  O.P. Dudanova, O.I. Kiselev
  Petrozavodsk, 2012, 80 p.
• Influenza: Epidemiology, Virology, Prevention and Treatment. Conference for Young Scientists. Collected Papers
  Edited by: L.M. Tsybalova, Dr.Med.Sci, V.V. Egorov, PhD
  St. Petersburg, 2012, 70 p.
• Influenza: Epidemiology, Virology, Prevention and Treatment. 45th Anniversary Conference Proceedings
  Epub(pdf), 2012, 42 p.
• Influenza: Epidemiology, Diagnosis, Prevention and Treatment
  Monograph. Edited by: O.I.Kiselev, L.M. Tsybalova, V.I. Pokrovsky
  Moscow, 2012, 496 p.
• Avian Influenza. The Origin of Biological Disasters. 2nd edition
  edited by V.I. Pokrovsky et al.
  St. Petersburg, 2012, Rostok, 304 p.
• Influenza and Pregnancy: Combination of Functional and Infectional Immunosuppression
  O.I.Kiselev, V.I. Pokrovsky
  St. Petersburg, 2012, 148 p.
• Chemo Drugs and Influenza Chemotherapy
  O.I.Kiselev
  St. Petersburg, 2012, Rostok, 272 p.

2011

1. Influenza: Epidemiology, Prevention and Treatment. Articles and Abstracts
   St. Petersburg, 2011, NP–Print, 72 p. 
2. Genome of Pandemic Influenza A/H1N1–2009/10 Virus.
   O.I.Kiselev
   St. Petersburg–Moscow, 2011, Dimitrade Graphic Grougp, 164 p.
3. Topical Problems of Socially Significant Viral Infections. Materials of the 10th Anniversary Russian–Italian Conference
   Edited by O.I.Kiselev, DrBiolSci., G.S. Arkhipov, DrMedSci., E.I. Arkhipova, DrMedSci.
   Velikiy Novgorod, 2011, ZAO «Novgorodskiy Technopark», 172 p.
4. Guidelines for Virus Isolation, Influenza IFA and PCR Diagnosis and Submitting Sentinel Surveillance Data Online
   St. Petersburg, 2011, 68 p.
5. Isolation, antigenic analysis and biological properties of pandemic influenza viruses A(H1N1)v circulated in Russian Federation in the epidemic season 2009-2010
   Eropkin M.U., Danilenko D.M., Konovalova N.I., Grigorieva V.A., Ivanova A.I., Gudkova T.M., Grigorieva V.A., Smirnova T.S.
   Turkish Journal of Clinical Laboratory. – 2011. – Vol. 2, № 1. – P. 27-33.
6. Differential cell culture susceptibility and proliferative response to avian, human, and swine influenza viruses
   Danilenko D.M., Smirnova T.D., Gudkova T.M., Eropkin M.Yu., Kiselev O.I.
   Influenza and Other Respiratory Viruses. – 2011. - Vol. 5, Suppl. 1. – P. 54-59.
7. Pandemic influenza in Russia: detection and molecular characterization of the H1N1v virus
   Grudinin M., Komissarov A., Pisareva M., Stukova M., Buzitskaya J., Elpaeva E., Slita A., Romanovskaya-Romanko E., Azarenok A., Prochukhanova A., Kiselev O.
   Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 395-397.
8. Pandemic influenza 2009 in Russia: isolation, antigenic analysis, and biological properties of viruses
   Eropkin M.Y., Danilenko D.M., Konovalova N.I., Ivanova A.V., Gudkova T.M., Grigorieva V.A.
   Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 416-418.
9. Comparison of influenza outbreaks in the Republic of Kazakhstan and Russia induced by 2009 yearly new variant of á(H1N1) influenza virus
   Karpova L.S., Popovtseva N.M., Stolyarova T.P., Stolyarov K.A., Mamadaliyev S.M., Khairullin B.M., Sandybayev N.T., Kydyrbayev Zh.K., Orynbayev M.B., Ospanov K.S., Baiserkin B.S., Boibosinov E.U.
   Virologica Sinica. – 2011. – Vol.26, № 5. – P. 306-314.
10. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture
    Roethl E., Gassner M., Krenn B.M., Romanovskaya-Romanko E.A., Seper H., Romanova J., Nakowitsch S., Sturlan S., Wolschek M., Sirotkin A., Kiselev O., Muster T., Egorov A.
    Journal of Virology. – 2011. – Vol. 85, № 21. – P. 11139-11145.
11. Modeling of self-organization of two-dimensional ordered structures
    Egorov V.V., Garmay Y.P., Shaldzhyan A.A., Lebedev D.V., Vasin A.V., Grudinina N.A., Kiselev O.I.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012005. DOI: 10.1088/1742-6596/291/1/012005
12. Multisegment one-step RT-PCR fluorescent labeling of influenza A virus genome for use in diagnostic microarray application
    Vasin A.V., Sandybaev N.T., Plotnikova M.A., Klotchenko S.A., Chervyakova O.V. Strochkov V.M., Taylakova E.T., Elpaeva E.A., Komissarov A.B., Egorov V.V., Koshemetov J.K., Kiselev O.I., Mamadaliev S.M.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012006. DOI: 10.1088/1742-6596/291/1/012006
13. Expression in E. coli and purification of the fibrillogenic fusion proteins TTR-sfGFP and β2M-sfGFP
    Solovyov K.V., Polyakov D.S., Grudinina N.A., Egorov V.V., Morozova I.V., Aleynikova T.D., Shavlovsky M.M.
    Preparative Biochemistry and Biotechnology. – 2011. – Vol. 41, № 4. – P.337-349.
14. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
    Krenn B.M., Egorov A., Romanovskaya-Romanko E., Wolschek M., Nakowitsch S., Ruthsatz T., Kiefmann B., Morokutti A., Humer J., Geiler J., Cinatl J., Wressnigg N., Sturlan S., Ferko B., Batishev O.V., Indenbom A.V., Zhu R ., Kastner M ., Hinterdorfer P., Kiselev O., Muster T., Romanova J.
    PLoS One. – 2011. – Vol. 6, № 4, e 18577. DOI: 10.1371/journal.pone.0018577
15. Antiviral activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol and its derivatives against influenza A(H1N1)2009 virus
    Ardashov O.V., Zarubaev V.V., Shtro A.A., Korchagina D.V., Volcho K.P., Salakhutdinov N.F., Kiselev O.I.
    Letters in Drug Design & Discovery. – 2011. – Vol. 8, № 4. – p. 375-380.
16. Dependence of biological effects of fullerene C60 in vitro from the type of preparations
    Piotrovsky L.B., Dumpis M.A., Litasova E.V., Eropkin M.Yu., Eropkina E.M., Kiselev O.I.
    Fullerenes, Nanotubes and Carbon Nanostructures. – 2011. – Vol. 19, № 1. – P. 147-153.
17. Birch bark extract as therapy for chronic hepatitis C – A pilot study
    Shikov A. N., Djachuk G. I., Sergeev D. V., Pozharitskaya O. N., Esaulenko E. V., Kosman V. M., Makarov V. G.
    Phytomedicine. – 2011. – Vol.18, № 10. – P.807-810.

2010

1. Influenza Pandemic 2009/2010: Antiviral Therapy and Treatment Schemes
   O.I. Kiselev ,F.I. Ershov, A.T. Bykov, V.I. Pokrovsky
   2010, A–Print, 100 p.
2. «Antiviral properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B virus replication»
   Karpenko I., Deev S., Kiselev O., Charushin V., Rusinov V., Ulomsky E., Deeva E., Yanvarev D., Ivanov A., Smirnova O., Kochetkov S., Chupakhin O, .Kukhanova M.
   Antimicrobial Agents and Chemotherapy - 2010. –V. 54. # 5 – P. 2017-2022
3. «Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus»
   Zarubaev V. V., Golod E. L., Anfimov P. M., Shtro A. A., Saraev V. V., Gavrilov A. S., Logvinov A. V., Kiselev O. I.
   Bioorg. Med. Chem. 2010, V. 18 – P.839-848.
4. «Determination of total aminothiols and neuroactive aminoacids in plasma by high performance liquid chromatography with fluorescence detection»
   Pozdeev V. K., Pozdeyev N. V.
   Biochemistry (Moscow) supplement series B: Boimedical chemistry. -2010. – V. 4, № 3 - ò.288-295.
5. «Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1»
   Jerebtsova M., Klotchenko S., Artamonova T., Ammosova T., Washington K., Egorov V., Shaldzhyan A., Sergeeva M., Zatulovskiy E., Temkina O., Petukhov M., Vasin A., Khodorkovskii M., Orlov Yu., Nekhai S.
   Mol Cell Biochem DOI 10.1007/s11010-010-0614-3 Published online: 13 October 2010.

2009

1. «Development of a live-attenuated influenza B DelNS1 intranasal vaccine candidate»
   N. Wressnigg, D. Voss, T. Wolff, J. Romanova, T. Ruthsatz, I. Mayerhofer, M. Reiter, S. Nakowitsch, J. Humer, A. Morokutti, T. Muster, A. Egorov, C. Kittel
   Vaccine. – 2009. – Vol.27, № 21. – P.2851-2857
2. «Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice»
   N. Wressnigg, A.-P. Shurygina, T. Wolff, M. Redlberger-Fritz, T. Popow-Kraupp, T. Muster, A. Egorov, C. Kittel
   J. Gen. Virology. –2009. Vol. 90, pt. 2. – P. 366-374

Epidemic Situation